Archive for September, 2010
A-Power Energy Generation Systems, Ltd (APWR) Announces EPC Contract with Liancheng Thermal Power Plant
SHENYANG, China, Sept. 30 /PRNewswire-Asia-FirstCall/ — A-Power Energy Generation Systems, Ltd. (Nasdaq: APWR) (“A-Power” or the “Company”), a leading provider of distributed power generation systems in China and a fast-growing manufacturer of wind turbines, today announced the signing of an EPC contract to build two 12MW and two 75t/h power plant projects in Liancheng, a total contract value of RMB 242 million.
Mr. Jinxiang Lu, A-Power’s Chairman and CEO, commented, “We are very excited to see an additional win in our core distributed generation (DG) business in China. Our Liaoning Hi-Tech (GaoKe) Energy Group subsidiary continues to build a strong pipeline of business for A-Power, expanding our customer base, geographic footprint as well as gaining further expertise in the DG business.”
Liaoning Hi-tech (GaoKe) Energy Group, A-Power’s wholly-owned subsidiary and EPC (engineering, procurement, and construction) contractor for this project, will be responsible for all the planning, engineering, and construction within the power stations.
The Company anticipates that it will recognize revenue over the 19-month anticipated implementation period on the percentage of completion method it customarily employs for projects in its DG business.
About A-Power
A-Power Energy Generation Systems, Ltd. (“A-Power”), through its China-based operating subsidiaries, is a leading provider of distributed power generation systems in China and is expanding into the production of alternative power generation systems. Focusing on energy-efficient and environmentally friendly DG projects of 25MW to 400MW, A-Power also operates one of the largest wind turbine manufacturing facilities in China and in March 2009, entered into an agreement to establish a partnership with W2E Wind To Energy GmbH to produce wind turbine gearboxes in Shenyang, Liaoning Province. It also acquired Evatech, a designer and manufacturer of industrial equipment for amorphous-silicon (a-Si) photovoltaic (PV) panels, in 2010.
In addition to the establishment of strategic relationships with the world’s leading wind energy design and engineering companies, A-Power has formed joint research programs with Tsinghua University and the China Academy of Sciences to develop and commercialize other renewable energy technologies. For more information, please visit http://www.apowerenergy.com .
Safe Harbor Statement
This press release may contain forward-looking statements. Any such statement is made within the ‘safe harbor’ provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “may”, “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” and other similar statements. Statements that are not historical facts, including statements relating to anticipated future earnings, margins, and other operating results, future growth, construction plans and anticipated capacities, production schedules and entry into expanded markets are forward-looking statements. Such forward-looking statements, based upon the current beliefs and expectations of our management, are subject to risks and uncertainties, which could cause actual results to differ materially from the forward-looking statements, including but not limited to, the risk that: inclement weather conditions could adversely affect our operating results in particular quarters and/or fiscal years; we may experience construction, manufacturing and development delays on our projects which could adversely affect our financial condition and operating results; our limited operating history and recent entrance into new lines of business and jurisdictional markets may make it difficult for you to evaluate our business and future prospects; we may not be able to successfully develop our business in new jurisdictional markets, which would have a negative impact on the results of our operations derived from such new jurisdictional markets; our customers may not be able to obtain the financing required for these projects, and thus, we may not be able to derive revenues from such agreements, as well as other relevant risks detailed in our filings with the Securities and Exchange Commission, including those set forth in our annual report filed on Form 20-F for the fiscal year ended December 31, 2009. The information set forth herein should be read in light of such risks. We assume no obligation to update the information contained in this press release, except as required under applicable law.
For more information, please contact: A-Power Energy Generation Systems John S. Lin Chief Operating Officer Email: john@apowerenergy.com ICR, LLC. Mr. Bill Zima Phone: +1-203-682-8233 Email: Bill.zima@icrinc.com
Good Times Restaurants Inc. (GTIM) Reports Improved Sales Trends
Sep. 30, 2010 (Business Wire) — Good Times Restaurants Inc. (NASDAQ: GTIM) today announced that its same store sales declines have reversed to a positive trend, from a decline of 1.7% in July to increases of +.4% in August and approximately +7% in September. Commenting on the recent same store sales trends, President & CEO Boyd Hoback said, “Our recent turnaround in sales trends reflects traction with consumers around several menu initiatives over the last six months including establishing our longer term value proposition around $2.89 Craver Combos, introducing Fresh Cut Fries and Hand Spun Custard Shakes and other product enhancements to improve and differentiate Good Times from the mainstream fast food pack. We recently rolled out Sweet Potato Waffle Fries as a seasonal limited time offering and are seeing very good results and anticipate that we will be able to continue to see improvements from last year’s poor sales trend. We have additional product launches planned and a new strategic marketing team that will leverage our historical brand personality.”
The Company also reported that it is continuing to seek and negotiate strategic financing alternatives for additional growth and working capital.
Good Times is a regional chain of quick service restaurants located primarily in Colorado providing a menu of high-quality all-natural hamburgers, 100% breast of chicken sandwiches, fresh frozen custard, fresh squeezed lemonades and other unique offerings. Good Times currently operates and franchises 49 restaurants.
This press release contains forward-looking statements within the meaning of federal securities laws. The words “intend,” “may,” “believe,” “will,” “should,” “anticipate,” “expect,” “seek” and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, which may cause Good Times’ actual results to differ materially from results expressed or implied by the forward-looking statements. These risks include such factors as the uncertain nature of current restaurant development plans and the ability to implement those plans, delays in developing and opening new restaurants because of weather, local permitting or other reasons, increased competition, cost increases or shortages in raw food products, and other matters discussed under the “Risk Factors” section of Good Times’ Annual Report on Form 10-KSB for the fiscal year ended September 30, 2009 filed with the SEC. Although Good Times may from time to time voluntarily update its forward-looking statements, it disclaims any commitment to do so except as required by securities laws.
Good Times Restaurants Inc.
Investor Relations Contacts:
Boyd E. Hoback, 303-384-1411
President and CEO
or
Christi Pennington, 303-384-1440
Executive Assistant
AirMedia (AMCN) Renews its Concession Rights Contract with China Southern Airlines
BEIJING, Sept. 30 /PRNewswire-Asia-FirstCall/ — AirMedia Group Inc. (“AirMedia”) (Nasdaq: AMCN), a leading operator of out-of-home advertising platforms in China targeting mid-to-high-end consumers, today announced that it recently renewed its concession rights contract with China Southern Airlines to operate digital TV screens on the airplanes of China Southern Airlines for five years from October 1, 2010, to September 30, 2015.
The renewed contract not only allows AirMedia to operate digital TV screens in the economy class but also the Video-on-Demand system and portable multi-media devices in the business class and first class on the airplanes of China Southern Airlines.
“China Southern Airlines is the largest airline in China in terms of air traveler volume. We have been receiving strong demand for advertising on digital TV screens on its airplanes. Our advertising time on digital TV screens on its airplanes was even oversold in some months in the past. The obtaining of advertising time in business class and first class will grant us more capacity to fulfill the strong demand of advertisers for advertising on the airplanes of China Southern Airlines,” remarked Herman Guo, chairman and chief executive officer of AirMedia. “The success of the contract renewal demonstrates our long-term trustworthy relationship with concession rights holders.”
About AirMedia Group Inc.
AirMedia Group Inc. (Nasdaq: AMCN) is a leading operator of out-of-home advertising platforms in China targeting mid-to-high-end consumers. AirMedia operates the largest digital media network in China dedicated to air travel advertising. AirMedia operates digital frames in 33 major airports, including the 15 largest airports in China. AirMedia also operates digital TV screens in 37 major airports, including 25 out of the 30 largest airports in China. In addition, AirMedia sells advertisements on the routes operated by nine airlines, including the four largest airlines in China. In selected major airports, AirMedia also operates traditional media platforms, such as billboards and light boxes, and other digital media, such as mega LED screens.
In addition, AirMedia has obtained exclusive contractual concession rights until the end of 2014 to develop and operate outdoor advertising platforms at Sinopec’s service stations located throughout China.
For more information about AirMedia, please visit http://www.airmedia.net.cn.
Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expect,” “anticipate,” “future,” “intend,” “plan,” “believe,” “estimate,” “confident” and similar statements. Among other things, the quotations from management in this announcement, as well as AirMedia’s strategic and operational plans, contain forward-looking statements. AirMedia may also make written or oral forward-looking statements in its reports to the U.S. Securities and Exchange Commission, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about AirMedia’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. Potential risks and uncertainties include, but are not limited to: if advertisers or the viewing public do not accept, or lose interest in, our air travel advertising network, we may be unable to generate sufficient cash flow from our operating activities and our prospects and results of operations could be negatively affected; we derive most of our revenues from the provision of air travel advertising services, and any slowdown in the air travel advertising industry in China may materially and adversely affect our revenues and results of operation; our strategy of expanding our advertising network by building new air travel media platforms and expanding into traditional media in airports may not succeed, and our failure to do so could materially reduce the attractiveness of our network and harm our business, reputation and results of operations; if we do not succeed in our expansion into gas station and other outdoor media advertising, our future results of operations and growth prospects may be materially and adversely affected; if our customers reduce their advertising spending or are unable to pay us in full, in part or at all for a period of time due to an economic downturn in China and/or elsewhere or for any other reason, our revenues and results of operations may be materially and adversely affected; we face risks related to health epidemics, which could materially and adversely affect air travel and result in reduced demand for our advertising services or disrupt our operations; if we are unable to retain existing concession rights contracts or obtain new concession rights contracts on commercially advantageous terms that allow us to operate our advertising platforms, we may be unable to maintain or expand our network coverage and our business and prospects may be harmed; a significant portion of our revenues has been derived from the five largest airports and three largest airlines in China, and if any of these airports or airlines experiences a material business disruption, our ability to generate revenues and our results of operations would be materially and adversely affected; our limited operating history makes it difficult to evaluate our future prospects and results of operations; and other risks outlined in AirMedia’s filings with the U.S. Securities and Exchange Commission. AirMedia does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
Investor Contact:
Raymond Huang | |
Investor Relations Director | |
AirMedia Group Inc. | |
Tel: +86-10-8460-8678 | |
Email: ir@airmedia.net.cn | |
Caroline Straathof | |
IR Inside | |
Tel: +31-6-54624301 | |
Email: info@irinside.com |
RELM Wireless (RWC) Receives Orders for P25 Radios Totaling $3.2 Million
WEST MELBOURNE, Fla., Sept. 30 /PRNewswire/ — RELM Wireless Corporation (NYSE Amex: RWC) today announced that it has received orders totaling approximately $3.2 million from several different branches of the U. S. Military, of which approximately $2.7 million is for the Company’s new P25 trunked portable and mobile radios. These orders include products for all the major frequencies; VHF, UHF and 800MHz and will be deployed both domestically and internationally. It is anticipated that the orders will be fulfilled during the fourth quarter of 2010.
RELM President and Chief Executive Officer David Storey commented, “It is exciting to come out of the gate with substantial trunking orders almost immediately upon releasing our new trunked products. Equally important is our expanding footprint with the U.S. Military. These orders are from branches of the military with which we have not previously done business. We intend to make them believers in our extraordinary value and customer service. This serves as tangible evidence of the positive reputation and relationships we have forged. It is also a promising indicator that we are successfully broadening our addressable market with more products, frequencies and features. We plan to continue aggressive pursuit of this strategy, which we believe should yield more opportunities for growth.”
About APCO Project 25 (P25)
APCO Project 25 (P25), which requires interoperability among compliant equipment regardless of the manufacturer, was established by the Association of Public-Safety Communications Officials and is approved by the U.S. Department of Homeland Security. The shift toward interoperability gained momentum as a result of significant communications failures during events such as the 9/11 attacks and Hurricane Katrina. RELM was one of the first manufacturers to develop P25-compliant technology.
About RELM Wireless Corporation
As an American Manufacturer for more than 60 years, RELM Wireless Corporation has produced highspecification twoway communications equipment of unsurpassed reliability and value for use by public safety professionals and government agencies, as well as radios for use in a wide range of commercial and industrial applications. Advances include a broad new line of leading digital twoway radios compliant with APCO Project 25 specifications. RELM’s products are manufactured and distributed worldwide under BK Radio and RELM brand names. The Company maintains its headquarters in West Melbourne, Florida and can be contacted through its web site at www.relm.com or directly at 1-800-821-2900. The Company’s common stock trades on the NYSE Amex market under the symbol “RWC”.
This press release contains certain forward-looking statements that are made pursuant to the “Safe Harbor” provisions of the Private Securities Litigation Reform Act Of 1995. These forward-looking statements concern the Company’s operations, economic performance and financial condition and are based largely on the Company’s beliefs and expectations. These statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors and risks include, among others, the following: risks relating to the current financial crisis and adverse economic conditions; reliance on contract manufacturers; heavy reliance on sales to the U.S. Government; federal, state and local budget deficits and spending limitations; limitations in available radio spectrum for use by land mobile radios; general economic and business conditions amid the financial crisis; changes in customer preferences; competition; changes in technology; changes in business strategy; the debt and inventory levels of the Company; quality of management, business abilities and judgment of the Company’s personnel; and the availability, terms and deployment of capital. Certain of these factors and risks, as well as other risks and uncertainties, are stated in more detail in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and in the Company’s subsequent filings with the SEC. These forward-looking statements are made as of the date of this press release, and the Company assumes no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements.
SOURCE RELM Wireless Corporation
Trio-Tech (TRT) Fiscal 2010 Revenue Increases 85% to $37 Million
Sep. 30, 2010 (Business Wire) — Trio-Tech International (AMEX:TRT) announced today that revenue for the fourth quarter of fiscal 2010 tripled to $12,874,000 compared to $4,328,000 for the fourth quarter of fiscal 2009. Net income for the quarter was $323,000 compared to a loss of $683,000 for the same quarter last year.
Revenue from product sales quadrupled to $8,865,000 for the fourth quarter of fiscal 2010 compared to $2,188,000 a year earlier, primarily the result of higher sales of the Company’s proprietary semiconductor test equipment products. Revenue from testing services for the fourth quarter of fiscal 2010 increased to $3,748,000 compared to $2,071,000 for the fourth quarter of fiscal 2009.
“We are pleased by the improved performance of our core semiconductor test equipment and services businesses, extending a trend that began late last year. We also are encouraged that manufacturing segment backlog at June 30, 2010 was a strong $7,181,000 compared to just $1,194,000 at June 30, 2009, and testing services backlog rose to $618,000 from $345,000, providing a solid foundation as we enter the new fiscal year,” said SW Yong, Trio-Tech’s CEO.
Yong added, “We began implementing expansion plans for our Malaysia manufacturing operation in the fourth quarter, including the purchase of additional plant and equipment, to improve efficiency and throughput to meet increasing orders from one of our major customers.
“We are also setting up a new 47,000 square foot facility for semiconductor test and burn-in services to support an existing major customer in Tianjin, China. Trio-Tech plans to invest $5.5 million over the next two years to equip this facility. The laboratory is certified for ISO and is currently undergoing buy-off by the major customer. We are expecting to commence operations towards the end of the second quarter or early third quarter of the current fiscal year.
“Trio-Tech is also beginning to realize returns on our investment in the real estate segment, as revenue from this segment increased to $183,000 in the fourth quarter, compared to $69,000 same quarter a year ago. Revenue at PT SHI Indonesia, a Batam-based oil and gas equipment fabricator which Trio-Tech acquired in fiscal 2010, was $78,000 for this year’s fourth quarter.
“We are committed to our strategy to add new sources of revenue and earnings to our core businesses, including PT SHI Indonesia, Trio-Tech Solar in Singapore and our real estate segments. Trio-Tech will continue to explore growth opportunities to increase shareholder value over the long term,” Yong said.
For the twelve months ended June 30, 2010, revenue increased 85% to $36,928,000 compared to $19,995,000 for fiscal 2009. The net loss from continuing operations for fiscal 2010 was $333,000, or $0.11 per share. This compares to a net loss from continuing operations for fiscal 2009 of $1,478,000, or $0.46 per share.
At June 30, 2010, Trio-Tech reported cash and cash equivalents, restricted term deposits and short-term deposits of $8,205,000 ($2.54 per outstanding share), working capital of $8,665,000, and shareholders’ equity of $20,266,000 ($6.28 per outstanding share). At June 30, 2009, cash and cash equivalents, restricted term deposits and short-term deposits were $11,468,000 ($3.55 per outstanding share), working capital was $10,475,000, and shareholders’ equity was $19,864,000 ($6.16 per outstanding share).
About Trio-Tech
Established in 1958 and headquartered in Van Nuys, California, Trio-Tech International is a diversified business group pursuing aggressive interest in semiconductor test and manufacturing, oil and gas equipment fabrication, solar products and real estate. Further information about Trio-Tech’s semiconductor products and services can be obtained from the Company’s Web site at www.triotech.com, www.universalfareast.com, www.shi-international.com and www.ttsolar.com.
Forward-Looking Statements
This press release contains statements that are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations, estimates and projections about the Company’s business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and the following: the effectiveness of the cost reduction initiatives undertaken by the Company, changes in demand for the Company’s products, product mix, the timing of customer orders and deliveries, the impact of competitive products and pricing, excess or shortage of production capacity, and other risks discussed from time to time in the Company’s Securities and Exchange Commission filings and reports. In addition, such statements could be affected by general industry and market conditions and growth rates, and general domestic and international economic conditions. Such forward-looking statements speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release.
TRIO-TECH INTERNATIONAL AND SUBSIDIARIES | ||||||||||||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME | ||||||||||||||||||
(IN THOUSANDS, EXCEPT EARNINGS PER SHARE) | ||||||||||||||||||
Three Months Ended | Twelve Months Ended | |||||||||||||||||
June 30, | June 30, | |||||||||||||||||
2010 | 2009 | 2010 | 2009 | |||||||||||||||
Revenue | ||||||||||||||||||
Products | $ | 8,865 | $ | 2,188 | $ | 23,493 | $ | 9,876 | ||||||||||
Services | 3,748 | 2,071 | 11,852 | 9,706 | ||||||||||||||
Fabrication services | 78 | — | 883 | — | ||||||||||||||
Others | 183 | 69 | 700 | 413 | ||||||||||||||
12,874 | 4,328 | 36,928 | 19,995 | |||||||||||||||
Cost of Sales | ||||||||||||||||||
Cost of products sold | 6,913 | 2,078 | 19,459 | 8,291 | ||||||||||||||
Cost of services rendered | 2,861 | 1,107 | 8,579 | 6,761 | ||||||||||||||
Cost of fabrication services rendered | 228 | — | 1,675 | — | ||||||||||||||
Others | 80 | 23 | 197 | 75 | ||||||||||||||
10,082 | 3,208 | 29,910 | 15,127 | |||||||||||||||
Gross Margin | 2,792 | 1,120 | 7,018 | 4,868 | ||||||||||||||
Operating Expenses | ||||||||||||||||||
General and administrative | 1,718 | 1,354 | 6,379 | 5,739 | ||||||||||||||
Selling | 125 | 88 | 535 | 367 | ||||||||||||||
Research and development | 10 | 9 | 39 | 39 | ||||||||||||||
Impairment loss | 438 | 4 | 438 | 323 | ||||||||||||||
Loss (gain) on disposal of property, plant and equipment | — | 78 | (5 | ) | (60 | ) | ||||||||||||
Total operating expenses | 2,291 | 1,533 | 7,386 | 6,408 | ||||||||||||||
Income (loss) from Operations | 501 | (413 | ) | (368 | ) | (1,540 | ) | |||||||||||
Other Income (Expenses) | ||||||||||||||||||
Interest expense | (47 | ) | (36 | ) | (170 | ) | (165 | ) | ||||||||||
Other income | 227 | (158 | ) | 386 | 320 | |||||||||||||
Total Other Income (expense) | 180 | (194 | ) | 216 | 155 | |||||||||||||
Income (loss) from Continuing Operations Before Income Tax | 681 | (607 | ) | (152 | ) | (1,385 | ) | |||||||||||
Income Tax Expense /(Benefit) | 350 | 52 | 400 | (51 | ) | |||||||||||||
Income (loss) from Continuing Operations | ||||||||||||||||||
before non-controlling interest, net of tax | 331 | (659 | ) | (552 | ) | (1,334 | ) | |||||||||||
LOSS FROM DISCONTINUED OPERATIONS, net of tax | (8 | ) | (24 | ) | (40 | ) | (488 | ) | ||||||||||
NET INCOME (LOSS) | $ | 323 | $ | (683 | ) | $ | (592 | ) | $ | (1,822 | ) | |||||||
Less: Net (loss) income attributable to the non-controlling interest | (76 | ) | (24 | ) | (219 | ) | 144 | |||||||||||
Net Income (loss) Attributable to Trio-Tech International | 399 | (659 | ) | (373 | ) | (1,966 | ) | |||||||||||
Net Income (loss) Attributable to Trio-Tech International Common Shareholders: | ||||||||||||||||||
Continuing Operations, net of tax | 407 | (635 | ) | (333 | ) | (1,478 | ) | |||||||||||
Discontinued Operations, net of tax | (8 | ) | (24 | ) | (40 | ) | (488 | ) | ||||||||||
Net Income (loss) | $ | 399 | $ | (659 | ) | $ | (373 | ) | $ | (1,966 | ) | |||||||
Comprehensive Income (Loss): | ||||||||||||||||||
Net Income (loss) | $ | 323 | $ | (683 | ) | $ | (592 | ) | $ | (1,822 | ) | |||||||
Foreign currency translation, net of tax | 61 | 555 | 734 | (866 | ) | |||||||||||||
Comprehensive Income (Loss) | 384 | (128 | ) | 142 | (2,688 | ) | ||||||||||||
Less: Comprehensive income (loss) attributable to the non-controlling interest | (140 | ) | 106 | (109 | ) | 110 | ||||||||||||
Comprehensive Income (loss) Attributable to Trio-Tech International | 524 | (234 | ) | 251 | (2,798 | ) | ||||||||||||
Income (loss) per share from Continuing operations – Basic and Diluted | $ | 0.12 | $ | (0.20 | ) | $ | (0.11 | ) | $ | (0.46 | ) | |||||||
Income (loss) per share from Discontinued operations – Basic and Diluted | 0.00 | (0.01 | ) | (0.01 | ) | (0.15 | ) | |||||||||||
Income (loss) per share – Basic and Diluted | $ | 0.12 | $ | (0.21 | ) | $ | (0.12 | ) | $ | (0.61 | ) | |||||||
Weighted Average Shares Outstanding – Basic and Diluted | 3,227 | 3,227 | 3,227 | 3,227 |
TRIO-TECH INTERNATIONAL AND SUBSIDIARIES | ||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||
(IN THOUSANDS, EXCEPT NUMBER OF SHARES) | ||||||||
June 30, | ||||||||
2010 | 2009 | |||||||
ASSETS | ||||||||
CURRENT ASSETS: | ||||||||
Cash & cash equivalents | $ | 3,244 | $ | 6,037 | ||||
Short-term deposits | 2,714 | 1,994 | ||||||
Trade accounts receivable, net | 12,142 | 3,981 | ||||||
Other receivables | 778 | 279 | ||||||
Inventories, net | 3,400 | 1,184 | ||||||
Investment in property development | 887 | 1,173 | ||||||
Prepaid expenses and other current assets | 296 | 167 | ||||||
Total current assets | 23,461 | 14,815 | ||||||
INVESTMENT PROPERTY IN CHINA, Net | 2,141 | 1,762 | ||||||
PROPERTY, PLANT AND EQUIPMENT, Net | 12,695 | 6,607 | ||||||
OTHER ASSETS | 1,180 | 1,326 | ||||||
RESTRICTED TERM DEPOSITS | 2,247 | 3,437 | ||||||
TOTAL ASSETS | $ | 41,724 | $ | 27,947 | ||||
LIABILITIES AND SHAREHOLDER’S EQUITY | ||||||||
CURRENT LIABILITIES: | ||||||||
Line of credit | $ | 2,532 | $ | — | ||||
Accounts payable | 7,968 | 1,025 | ||||||
Accrued expenses | 3,419 | 1,769 | ||||||
Income taxes payable | 342 | 202 | ||||||
Current portion of bank loans payable | 478 | 1,266 | ||||||
Current portion of capital leases | 57 | 78 | ||||||
Total current liabilities | 14,796 | 4,340 | ||||||
BANK LOANS PAYABLE, net of current portion | 2,566 | 237 | ||||||
CAPITAL LEASES, net of current portion | — | 52 | ||||||
DEFERRED TAX LIABILITIES | 718 | 526 | ||||||
OTHER NON-CURRENT LIABILITIES | 569 | 10 | ||||||
TOTAL LIABILITIES | 18,649 | 5,165 | ||||||
COMMITMENTS AND CONTINGENCIES | — | — | ||||||
EQUITY | ||||||||
TRIO-TECH INTERNATIONAL’S SHAREHOLDERS’ EQUITY: | ||||||||
Common stock; no par value, 15,000,000 shares authorized; 3,227,430 shares | ||||||||
issued and outstanding at June 30, 2010, and June 30, 2009, respectively | 10,365 | 10,365 | ||||||
Paid-in capital | 1,597 | 1,446 | ||||||
Accumulated retained earnings | 6,486 | 6,859 | ||||||
Accumulated other comprehensive loss-translation adjustments | 1,818 | 1,194 | ||||||
Total Trio-Tech International shareholders’ equity | 20,266 | 19,864 | ||||||
NON-CONTROLLING INTEREST | 2,809 | 2,918 | ||||||
TOTAL EQUITY | 23,075 | 22,782 | ||||||
TOTAL LIABILITIES AND EQUITY | $ | 41,724 | $ | 27,947 |
Uranium Energy Corp (UEC) Announces Major Advance with Permitting for Goliad ISR Project in South Texas
CORPUS CHRISTI, TX, Sept. 30 /CNW/ – Uranium Energy Corp (NYSE AMEX: UEC, the “Company”) is pleased to announce that the Company’s Goliad In-Situ Recovery (ISR) Project in South Texas has made a major advance toward becoming permitted for production. Yesterday, the administrative law judge who presided over a public hearing regarding the Company’s Goliad ISR Project in May of this year issued an initial Proposal for Decision (PFD).
In the PFD, the administrative judge recommended findings in favor of the Company on the vast majority of the issues from the hearing. He also recommended that the Texas Commission on Environmental Quality (TCEQ) allow the submission of additional data to address limited remaining issues.
In June 2009, the TCEQ’s Executive Director issued draft permits that would authorize the Company to install the initial wellfield and commence production at Goliad. During the hearing, the Executive Director re-affirmed its position that the permits should be issued. The hearing addressed questions and comments from the public regarding the Company’s mining plans and permits at Goliad. The administrative judge has now submitted an initial proposed decision to the TCEQ Commissioners, who have the authority and latitude to agree or disagree with his recommendations.
Harry Anthony, Chief Operating Officer, stated, “We look forward to submitting any additional data that is needed and to completing this phase of the permitting process. The Company is confident that the permits will be approved at the end of this process.”
The additional limited information for the administrative judge involves a 24-hour pump test at the Goliad project. The Company is pleased to have this test performed and to provide the data. The viability of operations at Production Area One or any future Production Areas is not affected by the results of the test.
About Uranium Energy Corp
Uranium Energy Corp. (NYSE-AMEX: UEC) is a U.S.-based exploration and development company with the objective of near-term uranium production in the U.S. The Company’s fully licensed and permitted Hobson processing facility is central to all of its projects in South Texas, including the fully-permitted Palangana in-situ recovery project, and the Goliad in-situ recovery project which is in the final stages of mine permitting for production. The Company’s operations are managed by professionals with a recognized profile for excellence in their industry, a profile based on many decades of hands-on experience in the key facets of uranium exploration, development and mining.
Stock Exchange Information:
<< NYSE-AMEX: UEC Frankfurt Stock Exchange Symbol: U6Z WKN: AØJDRR ISN: US916896103 >>
Safe Harbor Statement
Except for the statements of historical fact contained herein, the information presented in this news release constitutes “forward-looking statements” as such term is used in applicable United States and Canadian laws. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. Any other statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as “expects” or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans, “estimates” or “intends”, or stating that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved) are not statements of historical fact and should be viewed as “forward-looking statements”. Such forward looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such risks and other factors include, among others, the actual results of exploration activities, variations in the underlying assumptions associated with the estimation or realization of mineral resources, the availability of capital to fund programs and the resulting dilution caused by the raising of capital through the sale of shares, accidents, labour disputes and other risks of the mining industry including, without limitation, those associated with the environment, delays in obtaining governmental approvals, permits or financing or in the completion of development or construction activities, title disputes or claims limitations on insurance coverage. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements contained in this news release and in any document referred to in this news release.
Contact North America: Investor Relations, Uranium Energy Corp: Toll Free: (866) 748-1030, E-mail: info@ uraniumenergy.com
NetSol Technologies (NTWK) Regains Full NASDAQ Compliance
CALABASAS, Calif., Sept. 27, 2010 (GLOBE NEWSWIRE) — NetSol Technologies, Inc. (“NetSol” or the “Company”) (Nasdaq:NTWK) (Nasdaq Dubai:NTWK), a U.S. corporation providing global business services and enterprise application solutions to private and public sector organizations worldwide, today announced that NASDAQ has notified the Company that it has regained compliance with the minimum bid price requirement in Listing Rule 5550(a)(2) and met the requirements of the NASDAQ Listing Qualification Panel (the “Panel”) decision dated March 22, 2010. Accordingly, the Panel has determined to continue the listing of the Company’s common stock on the NASDAQ Capital Market exchange.
The letter from NASDAQ stated that on March 22, 2010, the Company was notified that its common stock failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days as required by the Listing Rules of the NASDAQ Stock Market. On September 23, 2010, the Company’s closing price was $1.39 per share, the tenth consecutive day it had exceeded the $1.00 per share threshold. Accordingly, NetSol has regained compliance with all applicable listing rules.
Najeeb Ghauri, Chairman and CEO of NetSol, stated, “As NetSol’s CEO, I am always very conscious of shareholder value and am pleased to be back in full compliance. I believe that our fundamentals and business offering are very strong, and our team is dedicated in executing our business plans and strategy. What we are trying to build in NetSol is unique and critical for our blue chip global customers. Even after the recent appreciation, our current stock price does not reflect the real worth of the Company, but we trust that the market is beginning to realize our true value and potential and will reward our shareholders accordingly.”
About NetSol Technologies, Inc.
NetSol Technologies, Inc. (Nasdaq:NTWK) (Nasdaq Dubai:NTWK) is a worldwide provider of global IT and enterprise application solutions. Since its inception in 1995, NetSol has used its BestShoring™ practices and highly experienced resources in analysis, development, quality assurance, and implementation to deliver high-quality, cost-effective solutions. Specialized by industry, these product and services offerings include credit and finance portfolio management systems, SAP consulting and services, custom development, systems integration, and technical services for the global Financial, Leasing, Insurance, Energy, and Technology markets. NetSol’s commitment to quality is demonstrated by its achievement of the ISO 9001, ISO 27001, and SEI (Software Engineering Institute) CMMI (Capability Maturity Model) Maturity Level 5 assessments, a distinction shared by 162 companies worldwide. NetSol Technologies’ clients include Fortune 500 manufacturers, global automakers, financial institutions, utilities, technology providers, and government agencies. Headquartered in Calabasas, California, NetSol Technologies has operations and offices in Alameda, Adelaide, Bangkok, Beijing, Karachi, Lahore, London, and Riyadh.
To learn more about NetSol, visit www.netsoltech.com.
The NetSol Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7396
NetSol Technologies, Inc. Forward-looking Statements
This press release may contain forward-looking statements relating to the development of the Company’s products and services and future operation results, including statements regarding the Company that are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected. The words “believe,” “expect,” “anticipate,” “intend,” variations of such words, and similar expressions, identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, but their absence does not mean that the statement is not forward-looking. These statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Factors that could affect the Company’s actual results include the progress and costs of the development of products and services and the timing of the market acceptance. The subject Companies expressly disclaim any obligation or undertaking to update or revise any forward-looking statement contained herein to reflect any change in the company’s expectations with regard thereto or any change in events, conditions or circumstances upon which any statement is based.
CONTACT: RedChip Companies, Inc. Investor Relations Contact: Jon Cunningham 800-733-2447, Ext. 107 407-644-4256, Ext. 107 info@redchip.com http://www.redchip.com
Gulf Resources (GFRE) Announces $10 million Share Repurchase Program
SHANDONG, China, Sept. 27 /PRNewswire-Asia-FirstCall/ — Gulf Resources, Inc. (Nasdaq: GFRE) (“Gulf Resources” or the “Company”), a leading manufacturer of bromine, crude salt and specialty chemical products in China, today announced that Gulf Resources’ Board of Directors has authorized a new share repurchase program under which the Company may acquire up to $10 million of its issued and outstanding common shares from time to time over the next 12 months. Any repurchases will be made on the open market at prevailing market prices or in block trades and subject to restrictions relating to volume, price and timing. Gulf Resources plans to fund repurchases from its available cash balance.
“Given our solid market leadership position, strong track record of business expansion and healthy balance sheet, we believe that our stock is deeply undervalued,” said Mr. Xiaobin Liu, Chief Executive Officer of Gulf Resources. “Our share repurchase program demonstrates the management’s commitment to enhance shareholders value as we remain on our growth path. Supported by the favorable bromine pricing environment, we are confident that this is an optimal opportunity to leverage our strong balance sheet and invest in Gulf Resources.”
About Gulf Resources, Inc.
Gulf Resources, Inc. operates through two wholly-owned subsidiaries, Shouguang City Haoyuan Chemical Company Limited (“SCHC”) and Shouguang Yuxin Chemical Industry Co., Limited (“SYCI”). The Company believes that it is one of the largest producers of bromine in China. Elemental Bromine is used to manufacture a wide variety of compounds utilized in industry and agriculture. Through SYCI, the Company manufactures chemical products utilized in a variety of applications, including oil & gas field explorations and as papermaking chemical agents. For more information about the Company, please visit http://www.gulfresourcesinc.cn .
Forward-Looking Statements
Certain statements in this news release contain forward-looking information about Gulf Resources and its subsidiaries business and products within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. The actual results may differ materially depending on a number of risk factors including, but not limited to, the general economic and business conditions in the PRC, future product development and production capabilities, shipments to end customers, market acceptance of new and existing products, additional competition from existing and new competitors for bromine and other oilfield and power production chemicals, changes in technology, the ability to make future bromine asset purchases, and various other factors beyond its control. All forward-looking statements are expressly qualified in their entirety by this Cautionary Statement and the risks factors detailed in the Company’s reports filed with the Securities and Exchange Commission. Gulf Resources undertakes no duty to revise or update any forward- looking statements to reflect events or circumstances after the date of this release.
For more information, please contact: Gulf Resources, Inc. David Wang, VP of Finance Email: gfre.2008@vip.163.com Helen Xu Email: beishengrong@vip.163.com Web: http://www.gulfresourcesinc.cn CCG Investor Relations Inc. Linda Salo, Sr. Financial Writer Phone: +1-646-922-0894 Email: linda.salo@ccgir.com Crocker Coulson, President Phone: +1-646-213-1915 Email: crocker.coulson@ccgir.com Website: http://www.ccgirasia.com
SOURCE Gulf Resources, Inc.
Gulf Resources, Inc., David Wang, VP of Finance, gfre.2008@vip.163.com, or Helen Xu, beishengrong@vip.163.com; CCG Investor Relations Inc., Linda Salo, Sr. Financial Writer, +1-646-922-0894, or linda.salo@ccgir.com; Crocker Coulson, President, +1-646-213-1915 or crocker.coulson@ccgir.com
Seattle Genetics (SGEN) and Millennium Announce Positive Top-Line Brentuximab Vedotin (SGN-35) Data
Sep. 27, 2010 (Business Wire) — Seattle Genetics, Inc. (Nasdaq: SGEN) and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced positive top-line results from the pivotal trial of single-agent brentuximab vedotin (SGN-35), an antibody-drug conjugate (ADC) targeted to CD30. The trial was conducted in 102 relapsed or refractory Hodgkin lymphoma (HL) patients.
Seventy-five percent of patients in the pivotal trial achieved an objective response as assessed by an independent central review, the primary endpoint of the trial. The median duration of response was greater than six months. The safety profile of brentuximab vedotin in this trial was generally consistent with prior clinical trial experience. A more complete data set will be presented at an upcoming scientific meeting.
“We are extremely excited with the top-line results, as they move us one step closer to our goal of bringing brentuximab vedotin to patients with relapsed or refractory Hodgkin lymphoma,” said Clay B. Siegall, Ph.D., President and Chief Executive Officer of Seattle Genetics. “We are positioned for a Biologics License Application (BLA) submission to the U.S. Food and Drug Administration (FDA) in the first half of 2011. In addition, we plan to report top-line data from our phase II trial of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma (ALCL) within the next few weeks.”
“The lack of adequate therapies for the treatment of relapsed and refractory Hodgkin lymphoma represents a substantial unmet medical need worldwide, with almost a third of the 30,000 newly diagnosed patients relapsing or becoming refractory to front-line therapy annually,” said Nancy Simonian, M.D., Chief Medical Officer of Millennium. “These data have the potential to provide an important advance in therapy for Hodgkin lymphoma. We intend to discuss these results with European regulators to support our goal of submitting a Marketing Authorization Application to the European Medicines Agency (EMA) in 2011.”
Pivotal Trial Design
The single-arm pivotal trial assessed efficacy and safety of single-agent brentuximab vedotin in relapsed or refractory, post-autologous stem cell transplant (ASCT) HL patients. Patients received 1.8 milligrams per kilogram of brentuximab vedotin every three weeks for up to 16 total doses. The primary endpoint of the trial was objective response rate as assessed by an independent review facility. Response assessments were based on the rigorous and internationally established Revised Response Criteria for Malignant Lymphoma (Cheson, 2007). Secondary endpoints included complete response rate, duration of response, progression-free survival, overall survival and tolerability. The trial was conducted under a Special Protocol Assessment (SPA) with the FDA and was discussed with the EMA during the process of obtaining EU Centralized Scientific Advice on the brentuximab vedotin development program. Brentuximab vedotin has been granted orphan drug designation by the FDA and EMA for the treatment of HL and ALCL and has been granted fast track designation by the FDA for HL.
About Brentuximab Vedotin
Brentuximab vedotin is an ADC comprising an anti-CD30 monoclonal antibody attached by an enzyme cleavable linker to a potent, synthetic drug payload, monomethyl auristatin E (MMAE) utilizing Seattle Genetics’ proprietary technology. The ADC employs a novel linker system that is designed to be stable in the bloodstream but to release MMAE upon internalization into CD30-expressing tumor cells. This approach is intended to spare non-targeted cells and thus may help minimize the potential toxic effects of traditional chemotherapy while allowing for the selective targeting of CD30-expressing cancer cells, thus potentially enhancing the antitumor activity.
In addition to the pivotal HL trial, Seattle Genetics and Millennium are conducting a phase II trial for relapsed and refractory systemic ALCL, a phase III clinical trial (the AETHERA trial) for patients at high risk of residual HL following autologous stem cell transplant, a phase II retreatment trial for relapsed patients who previously responded to brentuximab vedotin, and a phase I combination trial for front-line treatment of HL.
About Hodgkin Lymphoma
Lymphoma is a general term for a group of cancers that originate in the lymphatic system. There are two major categories of lymphoma: Hodgkin lymphoma and non-Hodgkin lymphoma. Hodgkin lymphoma is distinguished from other types of lymphoma by the presence of one characteristic type of cell, known as the Reed-Sternberg cell. A defining attribute of the Reed-Sternberg cell is its expression of the CD30 antigen.
According to the American Cancer Society, approximately 8,500 cases of Hodgkin lymphoma will be diagnosed in the United States during 2010 and more than 1,300 will die from the disease. Globally, there are more than 30,000 cases of Hodgkin lymphoma diagnosed each year. Although front-line combination chemotherapy can result in durable response rates, up to 30 percent of these patients relapse or are refractory to front-line treatment and have few therapeutic options beyond ASCT.
About the Seattle Genetics/Millennium Collaboration
Seattle Genetics and Millennium are jointly developing brentuximab vedotin. Under the terms of the collaboration agreement, Seattle Genetics has U.S. and Canadian commercialization rights and the Takeda Group has rights to commercialize brentuximab vedotin in the rest of the world. Seattle Genetics and the Takeda Group are funding joint development costs for brentuximab vedotin on a 50:50 basis, except in Japan where the Takeda Group will be solely responsible for development costs.
Conference Call Details
Seattle Genetics’ management will host a conference call and webcast to discuss this announcement. The event will be held today at 5:30 a.m. Pacific Time (PT); 8:30 a.m. Eastern Time (ET). The live event will be available from Seattle Genetics’ website at http://www.seattlegenetics.com, under the Investors and News section, or by calling (877) 941-8631 (domestic) or (480) 629-9819 (international). The access code is 4369251. A replay of the discussion will be available beginning at approximately 7:00 a.m. PT today from Seattle Genetics’ website or by calling (800) 406-7325 (domestic) or (303) 590-3030 (international), using access code 4369251. The telephone replay will be available until 5:00 p.m. PT on Friday, October 1, 2010.
About Seattle Genetics
Seattle Genetics is a clinical-stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. The company’s lead product candidate, brentuximab vedotin, is being evaluated in a variety of lymphoma treatment settings including the relapsed and refractory Hodgkin lymphoma indication for which top-line pivotal data have been reported. In addition, Seattle Genetics has four other clinical-stage programs: SGN-75, ASG-5ME, dacetuzumab (SGN-40) and SGN-70. Seattle Genetics has collaborations for its ADC technology with a number of leading biotechnology and pharmaceutical companies, including Bayer, Celldex Therapeutics, Daiichi Sankyo, Genentech, GlaxoSmithKline, MedImmune, a subsidiary of AstraZeneca, Millennium: The Takeda Oncology Company and Progenics, as well as ADC co-development agreements with Agensys, an affiliate of Astellas, and Genmab. More information can be found at www.seattlegenetics.com.
About Millennium
Millennium: The Takeda Oncology Company, a leading biopharmaceutical company based in Cambridge, Mass., markets a first-in-class proteasome inhibitor, and has a robust clinical development pipeline of product candidates. Millennium Pharmaceuticals, Inc. was acquired by Takeda Pharmaceutical Company Ltd. in May, 2008. The Company’s research, development and commercialization activities are focused in oncology. Additional information about Millennium is available through its website, www.millennium.com.
For Seattle Genetics: Certain of the statements made in this press release are forward looking, such as those, among others, relating to the potential therapeutic benefit of brentuximab vedotin and plans for filing for regulatory approval with and obtaining regulatory approval from the FDA and the EMA. Actual results or developments may differ materially from those projected or implied in these forward-looking statements. Factors that may cause such a difference include that the safety and/or efficacy results of the pivotal trial in relapsed or refractory Hodgkin lymphoma will not be sufficient to gain marketing approval in the United States or any other country, that we will be required to amend our submission for marketing approval or that such submission will be refused. In addition, our regulatory plans may change as a result of consultation with the FDA or EMA. More information about the risks and uncertainties faced by Seattle Genetics is contained in the company’s 10-Q for the quarter ended June 30, 2010 filed with the Securities and Exchange Commission. Seattle Genetics disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Virtual Radiologic and NightHawk Radiology (NHWK) Announce Merger
EDEN PRAIRIE, Minn. and SCOTTSDALE, Ariz., Sept. 27 /PRNewswire/ — Virtual Radiologic (vRad), a national radiology practice and leader in the development of radiologist workflow technology, and NightHawk Radiology (Nasdaq: NHWK), a leading provider of radiology solutions to radiology groups across the United States, today announced that they have entered into a definitive agreement under which vRad will acquire all of the outstanding common stock of NightHawk Radiology Holdings, Inc. for $6.50 per share in cash. The offer price represents a premium of 100% over NightHawk’s last closing stock price of $3.25 per share. The transaction is valued at approximately $170 million.
The combination of vRad and NightHawk will result in enhanced services to radiology groups and hospitals across the country, accelerating vRad’s stated commitment to optimize radiology’s critical role in the delivery of patient care. The combined entity will have 325 radiologists serving nearly 2,700 healthcare facilities across all 50 states and reading approximately 6 million studies annually. Additionally, more than 75 percent of the affiliated radiologists will be fellowship-trained subspecialists.
“Local radiology practices and hospitals are under intense pressure to deliver the highest quality care in the most efficient manner possible,” said vRad President and Chief Executive Officer Rob Kill. “The need for expanded access, improved quality, and reduced costs is clear. Both vRad and NightHawk have been delivering these benefits in partnership with local radiologists for many years. This combination – which brings together both companies’ talented team members and affiliated radiologists – will expand access to much-needed subspecialty expertise, helping to improve the quality of patient care across the United States. We look forward to working with NightHawk’s talented team to deliver the highest quality radiology service in the country.”
“We are pleased to deliver significant, immediate value to our stockholders through this transaction,” said NightHawk President and Chief Executive Officer David Engert. “The combination of our collective assets will enable us to better meet our clients’ rapidly expanding needs and will enhance our ability to partner with local radiologists to address the needs of local hospitals, physicians and the patients they serve. We look forward to working with Rob and the vRad team to ensure a seamless integration and to continuing to provide the quality and efficiency that our clients have come to expect.”
“We are very excited to bring together the strengths of our organizations,” said Eduard Michel, MD, neuroradiologist, Chief Medical Officer and vRad co-founder. “We each have implemented leading quality assurance programs that help ensure accuracy and provide a platform for clinical benchmarking. With our combined talents and experiences, we will be uniquely positioned to deliver new and innovative care delivery models to best serve our clients.”
Upon the completion of the transaction, Rob Kill will continue to serve as President and CEO of the combined organization. Dave Engert will remain as a Board Advisor following the close of the transaction. The remainder of the leadership team will be drawn from the management teams of both companies.
NightHawk’s Board of Directors unanimously approved the agreement and recommends that stockholders vote in favor of the transaction. The transaction is expected to be completed in the first quarter of 2011, subject to customary closing conditions, including the approval of NightHawk’s stockholders.
In conjunction with the merger agreement, a commitment for a senior secured credit facility was provided by GE Capital, Healthcare Financial Services. Morgan Stanley & Co., Incorporated is serving as financial advisor. Wilson Sonsini Goodrich & Rosati, Professional Corporation is serving as legal counsel to NightHawk. Weil, Gotshal & Manges LLP is serving as legal counsel to vRad. KPMG LLP is providing transaction and tax advisory services to vRad.
Additional Information and Where to Find It
In connection with proposed transaction, NightHawk will file with the Securities and Exchange Commission (SEC) a preliminary proxy statement and mail a definitive proxy statement and other relevant documents regarding the proposed transaction to NightHawk’s stockholders. NIGHTHAWK’S STOCKHOLDERS ARE URGED TO READ, WHEN AVAILABLE, NIGHTHAWK’S PRELIMINARY PROXY STATEMENT AND DEFINITIVE PROXY STATEMENT IN CONNECTION WITH NIGHTHAWK’S SOLICITATION OF PROXIES FOR THE SPECIAL MEETING TO BE HELD TO APPROVE THE PROPOSED TRANSACTION AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT NIGHTHAWK AND THE PROPOSED TRANSACTION. NightHawk’s stockholders may obtain a free copy of these documents, as well as other filings containing information about NightHawk, at the SEC’s website www.sec.gov. NightHawk’s stockholders will also be able to obtain, without charge, a copy of the proxy statement and any other relevant documents (when available) by directing a request to: 4900 N. Scottsdale Road, 6th Floor, Scottsdale, Arizona 85251, Attention: Investor Relations, or by telephone at (866) 400-4295 or through NightHawk’s website at www.nighthawkrad.net.
NightHawk and its directors and executive officers may be deemed to be participants in the solicitation of proxies from NightHawk’s stockholders in respect of the proposed transaction. Information about the directors and executive officers of NightHawk and their respective interests in NightHawk by security holdings or otherwise is set forth in its proxy statement for its 2010 Annual Meeting of Stockholders, which was filed with the SEC on March 19, 2010. Investors may obtain additional information regarding the interests of the participants by reading the proxy statement and other relevant documents regarding the proposed transaction when they become available.
Forward Looking Statements
This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from the statements made, including general economic conditions, competitive conditions in the radiology industry, and regulatory risks.
Such risks also include failure to satisfy the conditions of the proposed transaction, including failure to obtain the required approvals of NightHawk’s stockholders; the costs and expenses associated with the proposed transaction; contractual restrictions on the conduct of NightHawk’s business included in the merger agreement; the potential loss of key personnel, disruption of NightHawk’s business or any impact on NightHawk’s relationships with third parties as a result of the proposed transaction; any delay in consummating the proposed merger or the failure to consummate the transaction; and the outcome of, or expenses associated with, any litigation which may arise in connection with the proposed transaction.
Other factors that could cause NightHawk’s operating and financial results to differ are described in the company’s periodic reports filed with the SEC. Other risks may be detailed from time to time in reports to be filed with the SEC. NightHawk does not undertake any obligation to publicly update its forward-looking statements based on events or circumstances after the date hereof, except as required by law.
About Virtual Radiologic
Virtual Radiologic Corporation (vRad) is a privately owned national radiology practice working in partnership with local radiologists and hospitals to optimize radiology’s pivotal role in patient care. vRad’s more than 140 radiologists serve 1,200+ facilities, reading 2.7 million studies annually. Delivering access to extensive subspecialty coverage, vRad contributes to improved quality of patient care. And with its next-generation technology, vRad enhances productivity, helping to lower the overall cost of care while expediting time to diagnosis and treatment. For more information, visit www.vrad.com.
About NightHawk
NightHawk Radiology (NASDAQ: NHWK) is leading the transformation of the practice of radiology by providing high-quality, cost-effective solutions in the U.S. NightHawk provides the most complete suite of solutions, designed to increase efficiencies and improve the quality of patient care and the lives of radiologists. NightHawk’s team of U.S. board-certified, state-licensed, and hospital-privileged physicians are located in the United States, Australia, and Switzerland. They provide services 24 hours a day, 7 days a week, to nearly 1,500 sites. For more information, visit www.nighthawkrad.net.
NHWKF
SOURCE Virtual Radiologic
Kristen Biance, vRad, +1-813-690-0467, Kristen.biance@hillandknowlton.com, or Andrea Clegg, NightHawk, +1-208-292-2818, aclegg@nighthawkrad.net
SureWest (SURW) Authorizes Additional Stock Repurchases
ROSEVILLE, Calif., Sept. 23 /PRNewswire-FirstCall/ — SureWest Communications (Nasdaq: SURW) announced today that on September 22, 2010, the Board of Directors authorized an increase of one million shares of the company’s common stock to the previously authorized repurchase program. This stock repurchase program was originally approved in February 2000, and expanded in June 2002 and November 2006. This additional authorization increases the total amount previously available for repurchase under the program from approximately 253,000 shares to approximately 1,253,000 shares. The shares will be purchased in compliance with Rule 10b-18 of the Securities Exchange Act of 1934.
(Logo: http://photos.prnewswire.com/prnh/20050908/SFSUREWESTLOGO)
(Logo: http://www.newscom.com/cgi-bin/prnh/20050908/SFSUREWESTLOGO)
SureWest shares will be repurchased periodically in open market transactions or privately negotiated transactions at SureWest’s discretion, and subject to market conditions and other factors, including black-out periods during which the company and its insiders are prohibited from trading in the company’s common stock. While black-out periods typically occur after the end of a fiscal quarter in anticipation of the public release of quarterly earnings, the company may impose a black-out period at any time without advance public notice.
About SureWest
SureWest Communications (www.surewest.com) is a leading integrated communications provider and the bandwidth leader in the markets it serves. Headquartered in Northern California for more than 95 years, the company expanded into the Kansas City region in February 2008 with the acquisition of Everest Broadband, Inc. and offers bundled residential and commercial services that include IP-based digital and high-definition television, high-speed Internet, Voice over IP, and local and long distance telephone. SureWest was the nation’s first provider to launch residential HDTV over an IP network and offers one of the nation’s fastest symmetrical Internet services with speeds of up to 50 Mbps in each direction on its fiber-to-the-home network.
Safe Harbor Statement
Statements made in this news release that are not historical facts are forward-looking statements and are made pursuant to the safe harbor provisions of the Securities Litigation Reform Act of 1995. In some cases, these forward-looking statements may be identified by the use of words such as “may,” “will,” “should,” “expect,” “plan,” “anticipate” or “project,” or the negative of those words or other comparable words. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause the company’s actual results to differ from those projected in such forward-looking statements.
Important factors that could cause actual results to differ from those set forth in the forward-looking statements include, but are not limited to, advances in telecommunications technology, changes in the telecommunications regulatory environment, changes in the financial stability of other telecommunications providers who are customers of the company, changes in competition in markets in which the company operates, adverse circumstances affecting the economy in California, Kansas and Missouri in general, and in the greater Sacramento, California and greater Kansas City, Kansas and Missouri areas in particular, the availability of future financing, changes in the demand for services and products, new product and service development and introductions, and pending and future litigation.
Contacts: | |
Ron Rogers | |
Corporate Communications | |
916-746-3123 | |
r.rogers@surewest.com | |
Misty Wells | |
Investor Relations | |
916-786-1799 | |
m.wells@surewest.com |
Onstream Media (ONSM) to Receive $900,000 Investment from Lincoln Park Capital Fund, LLC
POMPANO BEACH, Fla., Sept. 24 /PRNewswire-FirstCall/ — Onstream Media Corporation (Nasdaq: ONSM), a leading online service provider of live and on-demand Internet broadcasting, corporate web communications and virtual marketplace technology, announced today that on September 17, 2010 it signed an agreement to sell its securities to Lincoln Park Capital Fund, LLC (“LPC”), a Chicago-based institutional investor. Under the agreement, LPC has agreed to invest gross proceeds of $900,000 in Onstream in exchange for 300,000 shares of common stock at $1.25 per share, preferred shares convertible into 420,000 shares of common stock at a fixed conversion price of $1.25 per share and a one-time commitment fee of 50,000 common shares. $1.25 per share represented an approximately 34% premium to the closing bid price of $0.93 per ONSM share on September 16, 2010, the day prior to entering into the agreement. Under the agreement, LPC will also receive warrants to purchase 540,000 shares of ONSM common stock at $2.00 per share.
“We are pleased to secure this investment from LPC, priced at a premium to market even after considering the NASDAQ computed value of the warrants. This investment accomplishes our financing goals of minimum dilution to our current investors and bringing on board a new fundamental institutional investor with a significant stake in the Company. It comes at an important time for us as we are continuing to execute on our legacy business, including audio and web conferencing, digital media services and webcasting, as well as the initial launch of our MarketPlace365™ product offering,” said Randy Selman, President and CEO of Onstream Media. “MarketPlace365, the latest addition to Onstream Media’s product line, continues to gain market acceptance as we have signed 16 MarketPlace365 promoter agreements to date. We believe that the adoption of MarketPlace365 speaks to its superior functionality and ease of use and suggests that is it helping promoters market in a cost effective and environmentally friendly way.”
Mr. Selman continued, “We believe that this investment by LPC at a premium to the market reflects a growing confidence in our novel product offerings, and specifically MarketPlace365, which has already been sold to customers such as Subway, the Tarsus Group (Onrec), the Human Capital Institute (HCI) and others, representing a new and significant growth opportunity for the Company. Furthermore, additional funding under the agreement will help us to invest in software development, equipment and marketing costs in connection with accelerating the advance of MarketPlace365 and our other product offerings.”
Terms of the Transaction
Pursuant to the Purchase Agreement between LPC and Onstream, Onstream will receive $900,000 as consideration for the initial purchase of 300,000 shares of common stock at $1.25 per share, 420,000 Series A-14 Preferred Stock with a stated value of $525,000 and convertible into common stock at a fixed price of $1.25 per share and warrants to purchase 540,000 shares of our common stock at an exercise price of $2.00 per share. LPC will also receive 50,000 shares of common stock as a one-time commitment fee and a cash payment of $26,250 as a one-time structuring fee. The warrants have a term of five years, are not exercisable for 6 months from issuance and are not being registered. Pursuant to a Registration Rights Agreement between LPC and Onstream, the shares of common stock and shares underlying the preferred stock will be offered by the Company through a prospectus supplement pursuant to a shelf registration statement, previously filed and declared effective by the Securities and Exchange Commission (SEC). In addition, the Company has the option at its sole discretion, to sell additional shares of common stock to LPC during the term of the Purchase Agreement, depending on certain conditions as set forth in that agreement. Should the Company elect to sell these additional shares, the purchase price would be fixed on the date of sale and based on the prevailing market prices of the Company’s shares for a period immediately preceding the sale.
The initial proceeds received by the Company under the Purchase Agreement will be used to retire certain debt and for general working capital purposes. Additional proceeds will be used for software development, equipment and marketing costs in connection with accelerating the advance of MarketPlace365 and our other product offerings.
A more detailed and complete description of the terms of the Purchase Agreement and the Registration Rights Agreement is set forth in the Company’s Current Report on Form 8-K recently filed with the SEC which the Company encourages be reviewed carefully. This press release does not and shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of the securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any state. Copies of the final prospectus supplement, once filed, and the accompanying base prospectus can be obtained from Onstream or at the SEC’s website at www.sec.gov.
About Lincoln Park Capital (“LPC”)
LPC is an institutional investor headquartered in Chicago, Illinois. LPC’s experienced professionals manage a portfolio of investments in public and private entities. These investments are in a wide range of companies and industries emphasizing life sciences, energy and technology. LPC’s investments range from multiyear financial commitments to fund growth to special situation financings to long-term strategic capital offering companies certainty, flexibility and consistency. For more information, visit www.LincolnParkCapital.com.
About Onstream Media:
Onstream Media Corporation (Nasdaq: ONSM) is a leading online service provider of live and on-demand Internet broadcasting, corporate web communications and virtual marketplace technology. Onstream Media’s innovative Digital Media Services Platform (DMSP) provides customers with cost effective tools for encoding, managing, indexing, and publishing content via the Internet. The company’s MarketPlace365™ solution enables publishers, associations, trade show promoters and entrepreneurs to rapidly and cost effectively self-deploy their own profitable, online virtual marketplaces. In addition, Onstream Media provides live and on-demand webcasting, webinars, web and audio conferencing services. To date, almost half of the Fortune 1000 companies and 78% of the Fortune 100 CEOs and CFOs have used Onstream Media’s services. Select Onstream Media customers include: AAA, Dell, Disney, Georgetown University, National Press Club, PR Newswire, Shareholder.com (NASDAQ), Sony Pictures and the U.S. Government. Onstream Media’s strategic relationships include Akamai, Adobe, BT Conferencing, Qwest and Trade Show News Network (TSNN). For more information, visit Onstream Media at www.onstreammedia.com or call 954-917-6655.
Cautionary Note Regarding Forward Looking Statements
Certain statements in this document and elsewhere by Onstream Media are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such information includes, without limitation, the business outlook, assessment of market conditions, anticipated financial and operating results, strategies, future plans, contingencies and contemplated transactions of the company. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors which may cause or contribute to actual results of company operations, or the performance or achievements of the company or industry results, to differ materially from those expressed, or implied by the forward-looking statements. In addition to any such risks, uncertainties and other factors discussed elsewhere herein, risks, uncertainties and other factors that could cause or contribute to actual results differing materially from those expressed or implied for the forward- looking statements include, but are not limited to fluctuations in demand; changes to economic growth in the U.S. economy; government policies and regulations, including, but not limited to those affecting the Internet. Onstream Media undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Actual results, performance or achievements could differ materially from those anticipated in such forward-looking statements as a result of certain factors, including those set forth in Onstream Media Corporation’s filings with the Securities and Exchange Commission.
Media Relations: | |
Chris Faust | |
Fastlane | |
973-226-4379 | |
cfaust@fast-lane.net | |
Aware (AWRE) Announces Plans to Spin-Off Patent Licensing Operations
BEDFORD, Mass., Sept. 24 /PRNewswire-FirstCall/ — Aware, Inc. (Nasdaq: AWRE), a leading technology innovator and software supplier to the telecommunications and biometrics industries, today announced its plans to pursue a spin-off of its patent licensing operations.
The spin-off will allow the spun-off entity to focus fully on patent licensing operations, including technology innovation, patent development and licensing. After the spin-off, Aware will continue as a leading supplier of test and diagnostics products and imaging and biometrics software.
Aware expects to file documents with the U.S. Securities & Exchange Commission (SEC) over the next few months and to complete the proposed transaction in the first half of fiscal 2011. The spin-off will result in two, independent publicly traded U.S. companies.
The proposed transaction is expected to be structured as a tax-free distribution to Aware stockholders, and is contingent upon a number of items including, but not limited to, receipt of a favorable ruling from the Internal Revenue Service as to the United States federal income tax consequences of the spin-off, a determination by Aware’s board of directors that the spin-off is in the best interest of Aware, and the completion of a review process by the SEC.
Aware also filed with the SEC today a proxy statement regarding a Special Meeting of Stockholders to approve amendments to existing equity plans to provide for an equity exchange program.
About Aware
Aware is a leading technology and supplier for the telecommunications and biometrics industries. Aware has pioneered innovations at telecommunications standards-setting organizations for DSL and networking. Telecom equipment vendors and phone companies use Aware’s DSL test and diagnostics modules and Dr. DSL® software to provision and troubleshoot DSL circuits globally. Aware is also a veteran of the biometrics industry, providing biometric and imaging software components used in government systems worldwide since 1992. Aware’s interoperable, standard-compliant, field-proven imaging products are used in a number of applications, from border management to criminal justice to medical imaging. Aware is a publicly held company (Nasdaq: AWRE) based in Bedford, Massachusetts. www.aware.com
More information about the proposal to approve amendments to Aware’s existing equity plans and the proposed equity exchange program is available in our proxy statement filed with the SEC on September 24, 2010. The proxy statement is available free of charge from the SEC’s website at www.sec.gov.
The equity exchange program described in the proxy statement has not yet commenced. The equity exchange program will only be commenced, if at all, if stockholders approve the amendments to Aware’s existing equity plans to permit the equity exchange program. Even if the requisite stockholder approval is obtained, Aware may still decide later not to implement the equity exchange program. Persons who are eligible to participate in the equity exchange program should read the Tender Offer Statement on Schedule TO, including the offer to exchange and other related materials, when those materials become available because they will contain important information about the equity exchange program. Aware will file the Tender Offer Statement on Schedule TO with the SEC upon the commencement of the equity exchange program. Aware’s stockholders and equity award holders will be able to obtain these written materials and other documents filed by Aware with the SEC free of charge from the SEC’s website at www.sec.gov.
Safe Harbor Warning
Portions of this release contain certain “forward-looking statements” including, but not limited to, statements regarding the form and timing of any transaction to spin-off the patent licensing operations. These statements are based on management’s current expectations and are subject to risks, uncertainty and changes in circumstances, which may cause actual results, performance or actions taken by Aware to differ materially from anticipated results, performance or actions. All statements contained herein that are not clearly historical in nature are forward-looking and the words “anticipate,” “believe,” “expect,” “estimate,” “plan,” and similar expressions are generally intended to identify forward-looking statements. Aware wishes to caution you that there are factors that could cause actual results to differ materially from the results indicated by such statements. General factors include, but are not limited to: our business is subject to rapid technological change; we face intense competition from a wide range of competitors; current economic conditions, including the credit crisis affecting the financial markets; our intellectual property is subject to limited protection; our ability to obtain or enforce patents could be affected by new laws, regulations or rules; and our business may be affected by government regulations. Further, there can be no assurance as to the timing of the contemplated spin-off, whether it will ultimately be structured as a spin-off, or whether it will be completed. Aware is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements whether as a result of new information, future events or otherwise. We refer you to the documents Aware files from time to time with the Securities and Exchange Commission, specifically the section titled Risk Factors in our annual report on Form 10-K for the fiscal year ended December 31, 2009, the interim reports filed on Form 10-Q for subsequent quarterly periods, and other reports and filings made with the Securities and Exchange Commission.
Aware and Dr. DSL are trademarks or registered trademarks of Aware, Inc. Any other trademarks appearing herein are the property of their respective owners.
SOURCE Aware, Inc.
Leap (LEAP) Announces Agreement to Acquire Chicago and Southern Wisconsin Operating Markets
SAN DIEGO, Sep 23, 2010 (BUSINESS WIRE) — Leap Wireless International, Inc., a leading provider of innovative and value-driven wireless communications services, announced today that Leap’s wholly owned operating subsidiary, Cricket Communications, Inc., has entered into an agreement to acquire all remaining interests in Denali Spectrum, LLC (Denali) and provide Cricket with ownership and control of Denali’s Greater Chicago and Southern Wisconsin markets. Cricket currently owns an 82.5% non-controlling membership interest in Denali. Under the purchase agreement, Cricket will acquire the remaining 17.5% controlling membership interest currently held by Denali Spectrum Manager, LLC (DSM).
Cricket also announced today that Denali has entered into an agreement to contribute its non-operating wireless licenses and spectrum lease to Savary Island Wireless, LLC (Savary Island), in exchange for an 85% non-controlling membership interest. Ring Island Wireless, LLC (Ring Island), will contribute cash to the venture in exchange for a 15% controlling membership interest. Savary Island is a newly-formed limited liability company that will apply to obtain its licenses as a “very small business” designated entity under applicable FCC rules. In connection with the contribution of Denali’s non-operating assets, Savary Island and its subsidiaries will assume approximately $211.6 million of the outstanding senior secured debt owed by Denali to Cricket. The closing of the transactions under the contribution agreement will occur immediately prior to the closing of Cricket’s purchase of DSM’s membership interest in Denali.
The transactions under the purchase agreement and the contribution agreement are subject to customary closing conditions, including the approval of the Federal Communications Commission. At the closing under the contribution agreement, Savary Island also will enter into a management services agreement with Cricket, pursuant to which Cricket will provide management and administrative services to Savary Island and its subsidiaries. Following the closings of these transactions, DSM will cease to own any direct or indirect equity interests in Denali or Savary Island, and DSM will have no further management of either enterprise.
“We are extremely pleased to have reached an agreement to acquire complete ownership of the Chicago and Southern Wisconsin operating markets,” said Doug Hutcheson, Leap’s president and chief executive officer. “We are also looking forward to working with our new partner, Ring Island Wireless, to realize value from the wireless licenses to be contributed to the Savary Island venture.”
About Leap
Leap provides innovative, high-value wireless services to a fast-growing, young and ethnically diverse customer base. With the value of unlimited wireless services as the foundation of its business, Leap pioneered its Cricket(R) service. The Company and its joint ventures operate in 35 states and the District of Columbia and hold licenses in 35 of the top 50 U.S. markets. Through its affordable, flat-rate service plans, Cricket offers customers a choice of unlimited voice, text, high-speed data and mobile Web services. Headquartered in San Diego, Calif., Leap is traded on the NASDAQ Global Select Market under the ticker symbol “LEAP.” For more information, please visit www.leapwireless.com.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements reflect management’s current expectations based on currently available operating, financial and competitive information, but are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those anticipated in or implied by the forward-looking statements. Our forward-looking statements are generally identified with words such as “will,” “believe,” “expect,” “intend,” “plan,” “could,” “may” and similar expressions. Risks, uncertainties and assumptions that could affect our forward-looking statements include, among other things, our ability to obtain FCC approval of the transactions under the purchase agreement and the contribution agreement, and other factors detailed in the section entitled “Risk Factors” included in our periodic reports filed with the SEC, including our Quarterly Report on Form 10-Q for the quarter ended June 30, 2010, filed with the SEC on August 6, 2010.
All forward-looking statements included in this news release should be considered in the context of these risks. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Investors and prospective investors are cautioned not to place undue reliance on our forward-looking statements.
SOURCE: Leap Wireless International, Inc.
Leap contacts: Amy Wakeham, Investor Relations 858-882-9876 awakeham@leapwireless.com or Greg Lund, Media Relations 858-882-9105 glund@leapwireless.com
New Energy Systems Group (NEWN) Reaffirms 2010 Guidance and Comments on Favorable Outlook for 2011
NEW YORK and SHENZHEN, China, Sept. 23 /PRNewswire-Asia-FirstCall/ — New Energy Systems Group (NYSE AMEX: NEWN) (“New Energy” or the “Company”), a vertically integrated original design manufacturer and distributor of lithium ion batteries and backup power systems, today reaffirmed revenue guidance of at least $88 million and adjusted net income guidance of at least $15.6 million, or $1.23 per share, for 2010. Adjusted net income excludes acquisition related amortization and non-cash stock compensation expense. The company believes adjusted net income is an important measure of its current and future operating performance.
Mr. Nian Chen, New Energy’s Chief Executive Officer, commented, “We continue to generate very strong organic growth within all four of our businesses, including Anytone, NewPower, our battery distribution business, and our battery shells and caps segment. In particular, our Anytone business is rapidly gaining market share within China due to strong demand for our back-up battery chargers. As a result, we are extremely confident in achieving or exceeding our previously issued guidance for 2010, and anticipate very strong top and bottom-line growth in 2011.”
“We are particularly excited about our foray into the U.S. market scheduled for later this year through the launch of our new MeePower(TM) brand of advanced battery backup systems and accessories. We anticipate that MeePower’s sales in the U.S. market will have higher gross margins than similar product sales in China.”
About New Energy Systems Group
New Energy Systems Group is a vertically integrated original design manufacturer and distributor of lithium ion batteries and backup power systems for mobile phones, laptops, digital cameras, MP3s and a variety of other portable electronics. The company’s end-user consumer products are sold under the Anytone brand in China, and the company has begun expanding its international sales efforts. The fast pace of new mobile device introductions in China combined with a growing middle class make it fertile ground for New Energy’s end-user consumer products, as well as its high powered, light weight lithium ion batteries. In addition to historically strong organic growth, New Energy is expected to benefit from economies of scale, broader distribution, greater production capacity and higher profit margins in 2010. Additional information about the company is available at: http://www.newenergysystemsgroup.com .
Forward Looking Statements
This release contains certain “forward-looking statements” relating to the business of the Company and its subsidiary and affiliated companies. These forward looking statements are often identified by the use of forward-looking terminology such as “believes,” “expects” or similar expressions. Such forward looking statements involve known and unknown risks and uncertainties that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company’s periodic reports that are filed with the Securities and Exchange Commission and available on its website (www.sec.gov). All forward-looking statements attributable to the Company or to persons acting on its behalf are expressly qualified in their entirety by these factors other than as required under the securities laws. The Company does not assume a duty to update these forward- looking statements.
For more information, please contact: Crescendo Communications, LLC David Waldman or Klea Theoharis Tel: +1-212-671-1020 Email: newn@crescendo-ir.com
WidePoint (WYY) Subsidiary iSYS Awarded $84 Million Five-Year Contract
WASHINGTON, Sept. 23 /PRNewswire/ — WidePoint Corporation (NYSE Amex: WYY), a specialist in wireless mobility management and cybersecurity solutions, today announced that its wholly owned subsidiary, iSYS LLC has been awarded a five-year contract which includes a base year and 4 option years, to provide wireless management services to the Transportation Security Administration (TSA). The contract award is valued at approximately $84 million for its five-year life cycle including all option periods.
“We are very happy for the opportunity to continue our support at TSA,” said Jin Kang, President of iSYS. “Having provided telecom expense management services to TSA since 2006, iSYS looks forward to the expanded scope of mobile management services we will provide to further support TSA’s vital mission.”
iSYS mobile management solutions combine industry expertise with the Company’s award-winning proprietary Intelligent Telecommunication Management System© (ITMS©) that meets Department of Defense Gold Disk Standards for IT Security. As the leading provider of mobile management services to the U.S. Federal Government, iSYS manages more wireless devices for more agencies than any other provider. iSYS expense management programs enable clients to gain visibility and control of wireless and telecom costs and establish standardized procurement and management procedures for wireless assets. iSYS wireless management solutions also support numerous State and Local agencies, enabling clients to gain customized insight into procurement optimization, compliance, invoice management, usage details and service activation.
WidePoint’s CEO, Steve L. Komar, said, “This award confirms iSYS’ leadership within the Federal TEM market space. It also marks an expansion of the TEM services at TSA, which we presently provide. It’s heartening to see the Federal Government’s continued use of TEM services to improve efficiency, streamline services and manage expenses.”
About iSYS:
iSYS (www.isysllc.com) is a leading provider of mobile and telecom management services and has delivered innovative Information Technology solutions to U.S. Federal, State and Local government agencies and commercial clients since 1999. iSYS solutions have generated more than $70 million in actual telecom cost savings for government agencies including the U.S. Department of Homeland Security, Administrative Office of the U.S. Courts, The Ohio State University, U.S. Customs and Border Protection, City of San Diego and the Centers for Disease Control and Prevention, among others.
About WidePoint:
WidePoint is a specialist in providing wireless mobility management and cybersecurity solutions utilizing its advanced information technology products and services. WidePoint has several wholly owned subsidiaries holding major government and commercial contracts including, Operational Research Consultants, Inc., iSYS, LLC, Protexx, Advanced Response Concepts Corporation and WidePoint IL. WidePoint enables organizations to deploy fully compliant IT services in accordance with government-mandated regulations and advanced system requirements. For more information, visit http://www.widepoint.com.
Safe-Harbor Statement under the Private Securities Litigation Reform Act of 1995: This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company’s financing plans; (ii) trends affecting the company’s financial condition or results of operations; (iii) the company’s growth strategy and operating strategy; (iv) the declaration and payment of dividends; and (v) the risk factors disclosed in the Company’s periodic reports filed with the SEC. The words “may,” “would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors including the risk factors disclosed in the company’s Forms 10-K and 10-Q filed with the SEC.
Tri-Valley Announces Significant Increase in Valuation of Its Pleasant Valley Oil Project
Sep. 23, 2010 (Business Wire) — Tri-Valley Corporation (NYSE Amex:TIV) today announced that an annual review of its Pleasant Valley oil sands project in Oxnard, California completed last month by an independent Canadian reserves engineering firm has resulted in a significant increase in its valuation compared with the prior year. The 2010 evaluation is effective from July 1, 2010, and the previous year’s assessment was effective from September 30, 2009.
The 2010 review of the Upper Vaca Tar reservoir for the Company’s Pleasant Valley project, undertaken by AJM Petroleum Consultants, Calgary, Alberta on behalf of the TVC OPUS 1 Drilling Program, L.P., the Company’s majority partner in the project, indicated a substantially higher valuation for the Company’s 25% interest in the heavy oil resource at Pleasant Valley. Based on AJM’s latest report, Tri-Valley’s share of total net proved, probable, and possible reserves is 4.9 million barrels, and its share of net contingent resources (“best estimate” value) is 1.5 million barrels.
Specifically, AJM’s estimate of undiscounted future net cash flow for the Company’s share of total net proved, probable, and possible reserves in the Pleasant Valley project increased to $304.0 million versus its 2009 estimate of $254.6 million. Tri-Valley’s share of estimated undiscounted net cash flow for net contingent resources (“best estimate” value) increased to $76.0 million compared with the 2009 estimate of $33.8 million. The increased 2010 estimates principally resulted from higher future oil prices, a higher netback price for the Upper Vaca Tar sales blend, lower capital costs, and lower fixed operating costs. Both the 2010 and 2009 evaluations assumed deployment of Steam Assisted Gravity Drainage or “SAGD” technology at Pleasant Valley which AJM determined as the most appropriate for maximizing recovery of oil from the Upper Vaca Tar reservoir.
“The increased valuation of the Pleasant Valley project is an important development for the Company and demonstrates in part the success of the operational improvements that we have put in place over the past year,” said Maston Cunningham, President and CEO of Tri-Valley Corporation. “The reductions in our costs of production and operating costs have positioned the Company for enhanced valuation of our oil and gas properties company-wide.”
The tables in attachments Exhibit I and Exhibit II provide additional details on the quantities and valuations of the Upper Vaca Tar oil reserves and contingent resources, respectively, at Pleasant Valley. Both the 2010 and 2009 estimates of reserves and contingent resources for the Upper Vaca Tar at Pleasant Valley were prepared in accordance with the Petroleum Resources Management System (PRMS) approved by the Society of Petroleum Engineers, the World Petroleum Council, the American Association of Petroleum Geologists, and the Society of Petroleum Evaluation Engineers. Such estimates may not be identical to estimates prepared in accordance with the current SEC rules for oil and gas disclosure.
About Tri-Valley
Tri-Valley Corporation explores for and produces oil and natural gas in California, and has two exploration-stage gold properties and a high grade calcium carbonate quarry in Alaska. Tri-Valley is incorporated in Delaware and is publicly traded on the NYSE AMEX exchange under the symbol “TIV.” Our company website, which includes all SEC filings, is www.tri-valleycorp.com.
Disclosure of Reserves and Resources
It should be noted that reserves and contingent resources involve different risks associated with achieving commerciality. There is no certainty that it will be commercially viable to produce any portion of the contingent resources described in this press release.
“Proved reserves” are those reserves that can be estimated with a high degree of certainty to be recoverable. It is likely that the actual remaining quantities recovered will exceed the estimated proved reserves.
“Probable reserves” are those additional reserves that are less certain to be recovered than proved reserves. It is equally likely that the actual remaining quantities recovered will be greater or less than the sum of the estimated proved plus probable reserves.
“Possible reserves” are those additional reserves that are less certain to be recovered than probable reserves. It is unlikely that the actual remaining quantities recovered will exceed the sum of the estimated proved plus probable plus possible reserves.
“Contingent resources” are those quantities of petroleum estimated, as of a given date, to be potentially recoverable from known accumulations using established technology or technology under development, but which are not currently considered to be commercially recoverable due to one or more contingencies. Contingencies may include factors such as economic, legal, environmental, political, and regulatory matters or a lack of markets. It is also appropriate to classify as contingent resources the estimated discovered recoverable quantities associated with a project in the early evaluation stage.
Resources are not, and should not be confused with, reserves.
There is no certainty that it will be commercially viable for the Company to produce any portion of the reserves or contingent resources detailed in this press release. The estimated future net revenues and values contained in this press release do not necessarily represent the market value of such reserves or resources. The high level of uncertainty associated with the Company’s possible recovery of any of these reserves or resources is the result of various risks and uncertainties including: current uncertainties around the specific scope and timing of the development of the Company’s oil sands properties; the ability of the Company to finance any potential oil sands projects; proposed reliance on technologies that have not yet been demonstrated to be commercially applicable in oil sands applications; lack of regulatory approvals; the uncertainty regarding marketing plans for production from the project; and improved estimation of project costs. There are a number of inherent risks and contingencies associated with such development, including commodity price fluctuations, project costs, and those other risks and contingencies discussed in more detail in the sections entitled “Forward-looking Statements” in this press release.
Forward-looking Statements
This press release contains forward-looking statements that involve risks and uncertainties. Actual results, events, and performance could vary materially from those contemplated by these forward-looking statements which includes such words and phrases as exploratory, wildcat, prospect, speculates, unproved, prospective, very large, expect, potential, etc. Among the factors that could cause actual results, events and performance to differ materially are risks and uncertainties discussed in “Item IA. Risk Factors” and “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” contained in the company’s Annual Report on Form 10-K for the year ended December 31, 2009 and in “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations” as disclosed in the Company’s Quarterly Report on Form 10-Q for the most recent quarter ended June 30, 2010.
Exhibit I | ||||||||
Tri-Valley Corporation | ||||||||
Reserves | ||||||||
Upper Vaca Tar – Oxnard, CA | ||||||||
July 1, 2010 | ||||||||
Reserves – Upper Vaca Tar (bbls thousands) | ||||||||
Proved
Producing |
Total
Proved |
Proved +
Probable |
Proved +
Probable+ Possible |
|||||
Gross Reserves | 967.9 | 4,044.6 | 7,267.4 | 26,347.4 | ||||
Net Reserves1 | 725.9 | 3,033.4 | 5,450.5 | 19,760.5 | ||||
Net to Tri-Valley2 | 181.5 | 758.4 | 1,362.6 | 4,940.1 | ||||
Net Reserves – Upper Vaca Tar ($US millions) | ||||||||
Net Present
Values |
Proved
Producing |
Total
Proved |
Proved +
Probable |
Proved +
Probable+ Possible |
||||
Undiscounted | 50.8 | 181.4 | 331.2 | 1,542.9 | ||||
5 Percent | 41.6 | 140.8 | 257.3 | 984.3 | ||||
10 Percent | 34.7 | 111.3 | 203.4 | 655.7 | ||||
15 Percent | 29.5 | 89.5 | 163.3 | 453.8 | ||||
Net Reserves to Tri-Valley-Upper Vaca Tar ($US millions) | ||||||||
Net Present
Values |
Proved
Producing |
Total
Proved |
Proved +
Probable |
Proved +
Probable+ Possible |
||||
Undiscounted | 12.7 | 45.4 | 82.8 | 385.7 | ||||
5 Percent | 10.4 | 35.2 | 64.3 | 246.1 | ||||
10 Percent | 8.7 | 27.8 | 50.9 | 163.9 | ||||
15 Percent | 7.4 | 22.4 | 40.8 | 113.5 | ||||
1Net reserves after royalty for Tri-Valley and its partners | ||||||||
2Tri-Valley’s 25% share of net reserves | ||||||||
Exhibit II | ||||||
Tri-Valley Corporation | ||||||
Contingent Resources | ||||||
Upper Vaca Tar – Oxnard, CA | ||||||
July 1, 2010 | ||||||
Contingent Resources – Upper Vaca Tar (bbls thousands) | ||||||
Low Estimate | Best Estimate | High Estimate | ||||
Gross Resources | 5,804.5 | 7,738.4 | 29,138.5 | |||
Net Resources3 | 4,353.3 | 5,803.8 | 21,853.9 | |||
Net to Tri-Valley4 | 1,088.3 | 1,451.0 | 5,463.5 | |||
Net Resources–Upper Vaca Tar ($US millions) | ||||||
Net Present Values | Low Estimate | Best Estimate | High Estimate | |||
Undiscounted | 236.0 | 304.0 | 1,685.6 | |||
5 Percent | 174.6 | 222.4 | 1,045.1 | |||
10 Percent | 129.7 | 162.8 | 668.9 | |||
15 Percent | 96.4 | 118.8 | 439.2 | |||
Net Resources to Tri-Valley–Upper Vaca Tar ($US millions) | ||||||
Net Present Values | Low Estimate | Best Estimate | High Estimate | |||
Undiscounted | 59.0 | 76.0 | 421.4 | |||
5 Percent | 43.7 | 55.6 | 261.3 | |||
10 Percent | 32.4 | 40.7 | 167.2 | |||
15 Percent | 24.1 | 29.7 | 109.8 | |||
3Net contingent resources after royalty for Tri-Valley and its partners | ||||||
4Tri-Valley’s 25% share of net contingent resources |
NetSol (NTWK) Agrees to Terms for New Global Framework Agreement With Major Captive Auto Finance Company
CALABASAS, Calif., Sept. 23, 2010 (GLOBE NEWSWIRE) — NetSol Technologies, Inc. (“NetSol” or the “Company”) (Nasdaq:NTWK) (Nasdaq Dubai:NTWK), a U.S. corporation providing global business services and enterprise application solutions to private and public sector organizations worldwide, today announced that it has agreed upon terms for a new global framework agreement with a major captive auto finance company. Under the terms, NetSol would expand its service delivery to the client in nine countries and install the complete NetSol Financial Suite™ software solution in Japan, Korea and India.
Naeem Ghauri, President and Head of Global Sales at NetSol, commented, “Our client has launched a major new initiative to strengthen its market position. Their emphasis on customer satisfaction and quality aligns perfectly with NetSol’s mission to deliver top-quality products and services to customers worldwide. The new agreement will boost the financial value of our existing partnership, allowing NetSol to deploy greater resources to enhance the client’s experience.” The Company will release further details as they become available for public disclosure.
About NetSol Technologies, Inc.
NetSol Technologies, Inc. (Nasdaq:NTWK) (Nasdaq Dubai:NTWK) is a worldwide provider of global IT and enterprise application solutions. Since its inception in 1995, NetSol has used its BestShoring™ practices and highly experienced resources in analysis, development, quality assurance, and implementation to deliver high-quality, cost-effective solutions. Specialized by industry, these product and services offerings include credit and finance portfolio management systems, SAP consulting and services, custom development, systems integration, and technical services for the global Financial, Leasing, Insurance, Energy, and Technology markets. NetSol’s commitment to quality is demonstrated by its achievement of the ISO 9001, ISO 27001, and SEI (Software Engineering Institute) CMMI (Capability Maturity Model) Maturity Level 5 assessments, a distinction shared by 162 companies worldwide. NetSol Technologies’ clients include Fortune 500 manufacturers, global automakers, financial institutions, utilities, technology providers, and government agencies. Headquartered in Calabasas, California, NetSol Technologies has operations and offices in Alameda, Adelaide, Bangkok, Beijing, Karachi, Lahore, London, and Riyadh.
To learn more about NetSol, visit www.netsoltech.com.
The NetSol Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7396
NetSol Technologies, Inc. Forward-looking Statements
This press release may contain forward-looking statements relating to the development of the Company’s products and services and future operation results, including statements regarding the Company that are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected. The words “believe,” “expect,” “anticipate,” “intend,” variations of such words, and similar expressions, identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, but their absence does not mean that the statement is not forward-looking. These statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Factors that could affect the Company’s actual results include the progress and costs of the development of products and services and the timing of the market acceptance. The subject Companies expressly disclaim any obligation or undertaking to update or revise any forward-looking statement contained herein to reflect any change in the company’s expectations with regard thereto or any change in events, conditions or circumstances upon which any statement is based.
CONTACT: RedChip Companies, Inc. Investor Relations Contact: Jon Cunningham 800-733-2447, Ext. 107 407-644-4256, Ext. 107 info@redchip.com http://www.redchip.com
Origin Agritech Limited (SEED) Reaches Worldwide Agreement for Bt Gene
BEIJING–(BUSINESS WIRE)–Origin Biotechnology, a wholly-owned subsidiary of Origin Agritech Limited (NASDAQ: SEED – News) announced it has reached an comprehensive, worldwide agreement with the Institute of Plant Protection, Chinese Academy of Agricultural Sciences (CAAS). CAAS jointly own the rights to the internally developed Bt-gene. Bacillus thuringiensis or “Bt” is a common soil bacterium that produces crystals that are toxic to certain insects. Origin Biotechnology already possesses the rights to this genetic trait in domestic China, and has been passing this product through the Ministry of Agriculture regulatory trials. This particular Bt- gene, demonstrated to be effective in both laboratory and field environments, is novel to the consumer markets in that it has never been commercialized, and is protected by patents granted separately by China and USA separately.
For the life of the patent, Origin will possess exclusive rights to sell and develop field crops products that contain these technology traits worldwide, Origin will also receive exclusive rights to sub-license to any third parties to develop seed products that contain these traits. Origin Agritech will also receive the rights to improve and further develop enhancements on this Bt-gene.
As a result of this agreement, Dr. Gengchen Han, Chairman of Origin, reiterated, “Origin continues to demonstrate that it is the leading, technology-focused crop seed company in China and improve its global technology product portfolio. Our industry goals are consistent — to lead by serving farmers with unique enabling technology and services, producing, and protecting higher crop yields. We are focused on the production of higher quality seed products, whether proprietary or licensed.”
The highly-effective, dominant Bt control solution was discovered in 1901 and first used commercially in 1958. These insecticidal properties captured over 95 percent of the bio-pesticide market as of 2010, according to industry and academic reports. Over 30 subspecies and 800 different strains of this bacterium are used currently in a variety of control mechanism for several insects and their larva which feed on fruits, vegetables, and other cash crops including corn and cotton. Although highly toxic to insects, Bt is harmless to humans because the human body lacks the digestive enzymes needed to dissolve Bt protein crystals into their active form.
UPDATE OF ORIGIN GM PROGRAM
Phytase
World’s first transgenic phytase corn is expected to be commercially launched as the first genetically modified corn product in China as approved in November 2009. Phytase is currently used as an additive essential for the growth and development of all animals, and limits the amount of phosphorus waste in the environment. Phytase, as an additive for animal feed, is mandatory in Europe, Southeast Asia, South Korea, Japan, and Taiwan for environmental purposes. The worldwide phytase potential market size is US$500 million dollars, including US$200 million for China alone, according to the China Feed Industry Study. The corn seed market in China is estimated at over US$1 billion.
Glyphosate (Herbicide) Resistance
Glyphosate tolerance has passed the intermediate testing phase (Phase 2) and entered the environmental release testing phase (Phase 3). The company expects this product to be this to be the following product commercialized after Phytase. This glyphosate tolerance gene is able be stacked with the Bt gene. Introduced in the US in 1998, the use of glyphosate resistant corn grew from 950,000 acres in 1998 to 2.3 million acres in 1999 to 41 million acres by 2007, or at a compounded annual growth rate of 51.9%, according to the US Department of Agriculture. The rapid historical adoption rate indicates farmers find this trait to extremely valuable. The high level of adoption of these crops by farmers has also caused the reduction in value of the remaining herbicide market.
Since their introduction in 1996, over 75 million acres of genetically engineered glyphosate-resistant crops have been planted, making up 46% of the corn, 80% of soybean acres, and 70% of cotton acres in the US. These genetically engineered crops have been adopted by farmers because they are perceived to offer significant economic benefits over conventional crop and herbicide programs. The adoption of glyphosate-resistant crops has reduced costs for US farmers an estimated $1.2 billion. On the basis of recent adoption rates by growers around the world, it appears that glyphosate-resistant crops will continue to grow in number and in hectares planted.
Pest Resistance (Bt Corn)
Pest resistance (Bt Corn) has passed the intermediate testing phase (Phase 2)and entered the environmental release phase (Phase 3). In these phase 2 and 3 trials, these traits continue to perform as the best performing traits for pest resistance throughout China.
Bt crops produce a protein toxic to specific insects used in areas with high levels of infestations of targeted pests. Bt cotton, which controls varieties of the budworm and bollworm, was planted on 59 percent of U.S. cotton acreage and over 75 percent of the Chinese cotton acreage in 2010. Introduced in 1996 in the US, acreage of Bt corn has grown from 3.6 million acres in 1999 to 44 million acres by 2007, or at a compounded annual growth rate of 36.7%, according to the US Department of Agriculture. This Bt corn variety was planted on 49 percent of U.S. corn acreage in 2007.
About Origin
Founded in 1997 and headquartered in Beijing, Origin Agritech Limited (NASDAQ GS: SEED) is China’s leading, vertically-integrated agricultural biotechnology company specializing in research, development and production to supply the growing populations of China. Origin develops, grows, processes, and markets high quality, hybrid crop seeds to farmers throughout China and parts of Southeast Asia via a network of approximately 3,800 first-level distributors and 65,000 second-level distributors and retailers, and possesses a pipeline of genetically modified seed products including glyphosate resistant corn and Bt Corn. The first genetically modified corn seed product for China, Phytase corn, was approved in November 2009 of which Origin possesses exclusive rights. For further information, please log on www.originagritech.com.
Forward Looking Statements
This release contains forward-looking statements. All forward-looking statements included in this release are based on information available to us on the date hereof. These statements involve known and unknown risks, uncertainties and other factors, which may cause our actual results to differ materially from those implied by the forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “could,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “targets,” “goals,” “projects,” “continue,” or variations of such words, similar expressions, or the negative of these terms or other comparable terminology. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements. Neither we nor any other person can assume responsibility for the accuracy and completeness of forward-looking statements. Important factors that may cause actual results to differ from expectations include, but are not limited to, those risk factors discussed in Origin’s filings with the SEC including its transition report on Form 20-F filed with the SEC on January 14, 2010. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.
Texas Oncology (BSDM) Acquires Hyperthermia System from BSD Medical
SALT LAKE CITY–(BUSINESS WIRE)–BSD Medical Corporation (NASDAQ:BSDM – News) (the “Company” or “BSD”) announced today that Texas Oncology has acquired the BSD-500 Hyperthermia System (BSD-500). Texas Oncology is an affiliate of the United Network of US Oncology, the nation’s largest network of community-based oncologists devoted to advancing cancer care and improving the cancer patient experience. The acquisition of the BSD-500 by Texas Oncology significantly increases the number of patients who will have access to hyperthermia treatment.
“We have known for years that hyperthermia was a promising treatment against cancer in the laboratory. Thanks to many dedicated scientists and clinicians, we now have very good clinical data and an excellent delivery device to offer our patients. Texas Oncology, along with US Oncology, is very excited to bring this technology to our patients and our network of doctors,” said Barry N. Wilcox, MD, Chief of Radiation Oncology at Baylor University Medical Center and Texas Oncology physician.
Texas Oncology delivers high-quality cancer care with leading-edge technology and provides advanced treatment and therapy options to help patients in their fight against cancer. Texas Oncology, a pioneer in community-based cancer care, is an independent oncology practice with more than 300 physicians serving 100 sites of service throughout Texas and Southeastern New Mexico. Texas Oncology patients have the opportunity to take part in some of the most promising clinical trials in the nation for a broad range of cancers. Through its affiliation with US Oncology and the US Oncology Research network, Texas Oncology participates in innovative clinical trials from Phase I through Phase IV, and has played a role in the development of 42 Food and Drug Administration (FDA) approved cancer therapies.
The United Network of US Oncology is a nationwide physician network focused on advancing cancer care at the community level and on delivering the best cancer care for patients. US Oncology, and the more than one thousand physicians of the United Network of US Oncology, are committed to eradicating cancer through the collective use of their expertise, deep resources, and diverse cancer-fighting capabilities. With a focus on bringing patients world-class evidence-based treatments, the latest clinical trials in the community setting, and healthcare technology to enhance the overall patient experience, the United Network of US Oncology offers the vision and resources to help ensure the long-term success of community-based cancer care.
The BSD-500 Hyperthermia System is used to deliver therapeutic heating (hyperthermia) using either non-invasive (external) hyperthermia, which is delivered using antennas placed over the tumor, or interstitial hyperthermia, which is delivered using antennas that are inserted into the tumor, or a combination of both. The BSD-500 has received U.S. Food and Drug Administration (FDA) pre-market approval (PMA), which is the standard FDA approval required to market Class III medical devices in the United States, for the use of hyperthermia alone or in conjunction with radiation therapy for the treatment of certain tumors.
About BSD Medical Corporation
BSD Medical Corporation develops, manufactures, markets and services systems to treat cancer and benign diseases using heat therapy delivered using focused radiofrequency (RF) and microwave energy. BSD’s product lines include both hyperthermia and ablation treatment systems. BSD’s hyperthermia cancer treatment systems, which have been in use for several years in the United States, Europe and Asia, are used to treat certain tumors with heat (hyperthermia) while increasing the effectiveness of other therapies such as radiation therapy. BSD’s microwave ablation system has been developed as a stand-alone therapy to employ precision-guided microwave energy to ablate (destroy) soft tissue. The Company has developed extensive intellectual property, multiple products in the market and well established distribution in the United States, Europe and Asia. Certain of the Company’s products have received regulatory approvals and clearances in the United States, Europe and China. For further information visit BSD Medical’s website at www.BSDMedical.com.
Statements contained in this press release that are not historical facts are forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. All forward-looking statements are subject to risks and uncertainties detailed in the Company’s filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date on which such statements are made, and the Company undertakes no obligation to update such statements to reflect events or circumstances arising after such date.
China Precision Steel (CPSL) Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2010 Results
SHANGHAI, Sept. 22 /PRNewswire-Asia/ — China Precision Steel (Nasdaq:CPSL – News), a niche precision steel processing company principally engaged in producing and selling high precision cold-rolled steel products, today announced that it will conduct a conference call at 9:00 a.m. Eastern Time on Wednesday, September 29, 2010 to discuss the fourth quarter and year end fiscal 2010 results.
Joining Ms. Leada Li, Chief Financial Officer of China Precision Steel, will be Dan Carlson, Non-Executive Director.
To participate in the live conference call, please dial the following number fifteen minutes prior to the scheduled conference call time: 888-339-2688, international callers should dial 617-847-3007; conference passcode is 45711286.
If you are unable to participate in the call at this time, a replay will be available for 14 days starting on Wednesday, September 29, 2010 at 11:00 a.m. Eastern Time. To access the replay, dial 888-286-8010 and enter the passcode 20603237. International callers should dial 617-801-6888 and enter the same passcode.
This conference call will be broadcast live over the Internet and can be accessed by all interested parties by clicking on http://www.chinaprecisionsteelinc.com . Please access the link at least fifteen minutes prior to the start of the call to register, download, and install any necessary audio software. For those unable to participate during the live broadcast, a 90-day replay will be available shortly after the call by accessing the same link.
About China Precision Steel
China Precision Steel, Inc. is a niche precision steel processing company principally engaged in the production and sale of high precision, cold-rolled steel products and provides value added services such as heat treatment and cutting medium and high carbon hot-rolled steel strips. China Precision Steel’s high precision, ultra-thin, high strength (7.5 mm to 0.05 mm) cold-rolled steel products are mainly used in the production of automotive components, food packaging materials, saw blades and textile needles. The Company primarily sells to manufacturers in the People’s Republic of China and is expanding into overseas markets such as Nigeria, Thailand, Indonesia and the Philippines. China Precision Steel was incorporated in 2002 and is headquartered in Sheung Wan, Hong Kong. Additional information can be found at the Company’s website http://chinaprecisionsteelinc.com .
For more information, please contact: China Precision Steel Dan Carlson Email: DanielCarlson@comcast.net Elite IR Leslie J. Richardson, Partner Tel: +852-3183-0283 Email: Leslie.richardson@elite-ir.com
China Pharma Holdings, Inc. (CPHI) Successfully Completes Phase I Clinical Trials of New Anti-Drug-Resistance Antibiotic
HAIKOU CITY, China, Sept. 22 /PRNewswire-Asia-FirstCall/ — China Pharma Holdings, Inc. (“China Pharma”) (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that the Company has successfully completed Phase I clinical trials of its novel cephalosporin-based combination antibiotic.
Cephalosporin continues to be the most widely prescribed class of antibiotics in China. According to the SFDA, approximately 50% of antibiotic sales are derived from cephalosporin. Sales of cephalosporin antibiotics were estimated to be over $6 billion in 2009, and are projected to be $7.5 billion in 2010, $11 billion in 2012, and $17.4 billion in 2015[1]. Due to broad usage of antibiotics, including cephalosporin, drug resistance has become a significant issue in China. The Company believes its new combination antibiotic possesses substantial competitive advantages in this environment, and believes the market opportunity for this drug can reach $50 million within three years of product launch. The SFDA has designated the Company’s combination antibiotic as a Class 1 drug, which carries five-year exclusivity when approved.
The Company’s anti-drug-resistance antibiotic, which combines a 3rd generation cephalosporin and a beta-lactamase inhibitor, is expected to be indicated for a wide variety of infections throughout the body, including: upper and lower respiratory tract infections (especially for pneumonia and bronchitis), ear and nose infections, bacterial Septicemia, meningitis, skin and skin structure infections, bone and joint infections, abdominal infections (peritonitis, cholecystitis, etc.), upper and lower urinary tract infections, gonorrhea, and genital infections.
Greater prevalence of drug-resistant extended-spectrum beta-lactamase (ESBL) producing bacteria, such as the enterobacteriaceae family, has prompted numerous in vivo and in vitro studies of the efficacy of this combination. The combination has demonstrated 94.6% efficacy against bacteria strains resistant to the cephalosporin component alone[2]. Beyond this clear benefit, the combination exhibits greater spectrum of activity against microorganisms like anaerobic bacteria and pseudomonas, which are not susceptible to the cephalosporin component alone.
Phase I of the clinical trials focused on the study of clinical pharmacology as well as evaluation of safety on the human body, through observing tolerance and pharmacokinetics to provide support for dosage and drug delivery design. Subjects enrolled in the Company’s Phase I clinical trials were administered medicine in dosages that varied depending on their assigned subject groups. The drug tolerance trials included both single tolerance trials and multiple tolerance trials.
“We are very pleased to announce the successful completion of Phase I clinical trials of our new drug candidate with excellent results,” commented China Pharma’s CEO and President, Ms Zhilin Li. “Our novel combination drug addresses growing resistance to cephalosporin. One of the two primary ingredients in our combination product has been placed on the government’s essential drug list, boosting its overall usage in basic level hospitals, which may exacerbate resistance issues in the coming few years and provide an even greater opportunity for China Pharma. Both ingredients in our compound already have demonstrated their efficacy in stand alone form, so we are very optimistic about continued success in the clinical trials setting. We believe that our anti-drug-resistance antibiotic will provide a better therapeutic solution for hospitals, and will generate positive excitement among physicians and hospital professionals upon launch, especially given the limited number of new antibiotic compounds and new combination antibiotics coming to market.”
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. is a specialty pharmaceutical company with rapidly growing profit that develops, manufactures, and markets treatments for a wide range of high incidence and high mortality conditions in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company’s cost-effective, high margin business model is driven by market demand and supported by eight scalable GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding distribution network across 30 provinces, municipalities and autonomous regions. The Company is registered in Delaware, USA. Hainan Helpson Medical & Biotechnology Co., Ltd. (Helpson), located in Haikou City, Hainan Province, China, is a wholly owned subsidiary of China Pharma Holdings, Inc. For more information about China Pharma Holdings, Inc., please visit http://www.chinapharmaholdings.com .
Reference:
[1] MENET, SFDA, and InterFax-China News Agency “China – Pharmaceuticals & Health Technologies Weekly” Volume VI, Issue 29
[2] The Internet Journal of Infectious Diseases 2009: Volume 7 Number 2
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Certain statements in this press release constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Any statements set forth above that are not historical facts are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, which may include, but are not limited to, such factors as success of new product development, unanticipated changes in product demand, increased competition, downturns in the Chinese economy, uncompetitive levels of research and development, and other information detailed from time to time in the Company’s filings and future filings with the United States Securities and Exchange Commission. The forward-looking statements made herein speak only as of the date of this press release and the Company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company’s expectations.
For more information, please contact: | |
China Pharma Holdings, Inc. Phone: +86-898-6681-1730 (China) Email: hps@chinapharmaholdings.com |
|
CCG Investor Relations Kalle Ahl, CFA, Account Manager Phone: +1-646-833-3417 (New York) Email: kalle.ahl@ccgir.com |
|
Vivian Chen, Sr. Market Intelligence Exec. Phone: +1-646-701-7445(New York) Email: vivian.chen@ccgir.com |
China North East Petroleum Holdings Ltd. (NEP) Engages Ernst & Young (China) for Sarbanes-Oxley Compliance
HARBIN, China and NEW YORK, Sept. 22 /PRNewswire-Asia-FirstCall/ — China North East Petroleum Holdings Ltd. (the “Company” or “NEP”) (NYSE Amex: NEP), a leading independent oil producer and oilfield services company in Northern China, today announced that it has engaged Ernst & Young (China) Advisory Ltd. (“Ernst & Young” or “E&Y”) to assist the Company to comply with the requirements of Section 404 of the Sarbanes-Oxley Act Section of 2002 (“SOX 404”).
Ernst & Young will work closely with the Company’s management to help prepare a SOX 404 compliance program. As part of compliance with SOX 404, NEP and its external auditor will examine and report on the adequacy of the Company’s internal financial reporting and control systems after documenting and testing financial reporting and control procedures. In addition, Ernst & Young will provide recommendations to Company’s management for instituting necessary additional controls to enhance the risk management capability of the Company’s internal controls over financial reporting.
“We are pleased to engage E&Y to ensure that our Company is in full compliance with SOX 404 requirements,” said Mr. Edward Rule, Chairman of China North East Petroleum. “Our SOX 404 compliance work with E&Y can enhance our operations and risk management processes and create greater transparency for investors. We regard the responsibilities associated with the quality of our financial reporting and disclosure process very seriously and believe this undertaking can increase shareholder confidence in our stock and enhance the long-term value proposition of our Company.”
ABOUT CHINA NORTH EAST PETROLEUM
China North East Petroleum Holdings Limited is an independent oil company that engages in the production of crude oil in Northern China. The Company is a pioneer in China’s private oil exploration and production industry, and the first Chinese non-state-owned oil company trading on the NYSE Amex.
The Company has a guaranteed arrangement with the PetroChina to sell its produced crude oil for use in the China marketplace. The Company currently operates four oilfields in Northern China. The Company also recently added an oil service subsidiary through its acquisition of Song Yuan Tiancheng Drilling Engineering Co. Ltd. (“Tiancheng”). For more information about the Company, please visit http://www.cnepetroleum.com .
Statements in this press release, including but not limited to those relating to the Company’s or management’s intentions, beliefs, expectations, hopes, projections, assessment of risks, estimations, plans or predictions for the future, including the impact of the restatement, timing of filings with the SEC and other statements that are not historical facts are forward-looking statements that are based on current expectations. Although the Company believes that its expectations are based on reasonable assumptions, it can give no assurance that these expectations will prove correct. Important factors that could cause actual results to differ materially from those in the forward-looking statements include delays and uncertainties that may be encountered in connection with the restatement, final audits and reviews by the Company and its auditors, and other risks described in the Company’s annual report on Form 10-K for the year ended December 31, 2009 and its other filings with the SEC. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Investors should not place undue reliance on forward-looking statements. Each forward-looking statement speaks only as of the date of the particular statement and the Company undertakes no duty to update any forward-looking statement.
Arotech (ARTX) Receives $3.5 Million in Aviation Armor Orders
ANN ARBOR, MI — (Marketwire) — 09/21/10 — Arotech Corporation (NASDAQ: ARTX) announced today that its Armour of America (AoA) unit has received orders valued at $3.5 million for armoring helicopters and cargo aircraft.
AoA’s Aviation armor suites include protection for the cockpit and the cabin, and can easily be removed for operations outside the danger zone.
“AoA is a well-recognized brand in Aviation Armor,” said Robert Ehrlich, Arotech’s Chairman and CEO. “These new orders from various new and existing customers show promise for continued growth in our Aviation Armor sector,” concluded Ehrlich.
About Arotech’s Armor Division
Arotech’s Armor Division is an innovative leader in lightweight armoring for vehicles, aircraft and their operators. The Armor Division has years of battlefield and commercial protection experience and has provided life saving protection under the most extreme conditions.
Arotech’s Armor Division consists of MDT Armor Corporation (www.mdt-armor.com), MDT Protective Industries, Ltd. (www.mdtisrael.com), and Armour of America (www.armourofamerica.com).
About Arotech Corporation
Arotech Corporation is a leading provider of quality defense and security products for the military, law enforcement and homeland security markets. Arotech provides multimedia interactive simulators/trainers, lightweight armoring and advanced zinc-air and lithium batteries and chargers. Arotech operates through three major business divisions: Armor, Training and Simulation, and Batteries and Power Systems.
Arotech is incorporated in Delaware, with corporate offices in Ann Arbor, Michigan and research, development and production subsidiaries in Alabama, Michigan and Israel.
Except for the historical information herein, the matters discussed in this news release include forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management’s current knowledge, assumptions, judgment and expectations regarding future performance or events. Although management believes that the expectations reflected in such statements are reasonable, readers are cautioned not to place undue reliance on these forward-looking statements, as they are subject to various risks and uncertainties that may cause actual results to vary materially. These risks and uncertainties include, but are not limited to, risks relating to: product and technology development; the uncertainty of the market for Arotech’s products; changing economic conditions; delay, cancellation or non-renewal, in whole or in part, of contracts or of purchase orders; dilution resulting from issuances of Arotech’s common stock upon conversion or payment of its outstanding convertible debt, which would be increasingly dilutive if and to the extent that the market price of Arotech’s stock decreases; and other risk factors detailed in Arotech’s most recent Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and other filings with the Securities and Exchange Commission. Arotech assumes no obligation to update the information in this release. Reference to the Company’s website above does not constitute incorporation of any of the information thereon into this press release.
CONTACT:
Victor Allgeier
TTC Group
(646) 290-6400
Email Contact
Kingtone Wirelessinfo Solution Holding Ltd. (KONE) Announces Chairman’s Share Purchases
XI’AN, China, Sept. 21 /PRNewswire-Asia-FirstCall/ — Kingtone Wirelessinfo Solution Holding Ltd (“Kingtone” or the “Company”) (Nasdaq: KONE), a leading China-based software and solutions developer focused on wirelessly enabling businesses and government agencies to more efficiently manage their operations, today announced that the Company’s Chairman, Tao Li, acquired 430,798 American Depositary Shares (ADSs), with each ADS representing one Ordinary Share of Kingtone, from open market between September 9, 2010 and September 17, 2010. Mr. Li increased his total beneficial holdings of Kingtone’s Ordinary Shares from 6,099,107 to 6,529,905, or 46.6% of the Company’s total outstanding shares.
Mr. Li stated, “I am very confident in the future of our company. Kingtone is committed to becoming the national leading service provider of mobile technology development and value-added applications for China’s enterprises and mobile users. Over the past quarters since our IPO, our dedicated management and employees have continued to execute our strategy on delivering long-term sustainable growth. I firmly believe that Kingtone is well positioned to capture significant growth opportunities as the mobile communications industry continues to exhibit strong growth in China. I strongly expect that Kingtone will continue to deliver significant value to our shareholders in the long term.”
About Kingtone Wirelessinfo Solution Holding Ltd
Kingtone Wirelessinfo Solution Holding Ltd (Nasdaq: KONE) is a leading China-based software and solutions developer focused on wirelessly enabling businesses and government agencies to more efficiently manage their operations. The Company’s products, known as mobile enterprise solutions, extend a company’s or enterprise’s information technology systems to include mobile participants. The Company develops and implements mobile enterprise solutions for customers in a broad variety of sectors and industries, to improve efficiencies by enabling information management in wireless environments. At the core of its many diverse packaged solutions is proprietary middleware, which enables wireless interactivity across many protocols, devices, and platforms.
For more information, please visit Kingtone’s website at http://www.kingtoneinfo.com .
Safe Harbor Statements
This press release contains “forward-looking statements”, including certain plans, expectations, goals, and projections, which are subject to numerous assumptions, risks, and uncertainties. These forward-looking statements may include, but are not limited to, statements containing words such as “may,” “could,” “would,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “expects,” “intends” and “future” or similar expressions. These forward-looking statements speak only as of the date of this press release and are subject to change at any time. These forward- looking statements are based upon management’s current expectations and are subject to a number of risks, uncertainties and contingencies, many of which are beyond the Company’s control that may cause actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. The Company’s actual results could differ materially from those contained in the forward-looking statements due to a number of factors, including those described under the heading “Risk Factors” in the Company’s final prospectus, dated May 14, 2010, filed with the Securities and Exchange Commission, and in documents subsequently filed by the Company from time to time with the Securities and Exchange Commission. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise except to the extent by applicable law.
For investor and media inquiries, please contact: Ms. Ying Yang Chief Financial Officer Kingtone Wirelessinfo Solution Holding Ltd Phone: +1-626-623-2575 (US) +86-134-6895-0909 (China) Email: yangying@kingtoneinfo.com Christensen Tip Fleming Photo: +852-9212-0684 Email: tfleming@christensenir.com Kathy Li Phone: +1-480-614-3036 Email: kli@christensenir.com
VIVUS, Inc. (VVUS) New Long-Term Data on QNEXA® Show Significant and Sustained Weight Loss
MOUNTAIN VIEW, Calif., Sept. 21 /PRNewswire-FirstCall/ — VIVUS, Inc. (Nasdaq: VVUS) today announced positive top-line results from a two-year study of QNEXA® (phentermine/topiramate) Controlled Release Capsules, an investigational therapy for treatment of obesity, a condition that affects approximately one-third of adult Americans.
The findings come from the SEQUEL study (OB-305), a 52-week extension study for a subset of patients who completed the previously reported 56-week CONQUER study. The total study period was 108 weeks. SEQUEL included 675 obese or overweight patients, all of whom had two or more weight related co-morbidities, and an average baseline BMI of 36.1.
Patients in the study taking the top dose of QNEXA achieved and maintained average weight loss through two years of 11.4% of their initial body weight, or 26 pounds (ITT-LOCF). Consistent with the first year experience, QNEXA therapy was well tolerated, with no new or unexpected adverse events. The most common side effects seen were constipation, tingling, dry mouth, altered taste and insomnia.
Weight loss with QNEXA in SEQUEL was associated with statistically significant improvements in weight-related co-morbidities such as hypertension, dyslipidemia and diabetes. Among patients without diabetes at baseline, the incidence of new onset of type 2 diabetes was reduced by 54% and 76% (mid- and top-dose, respectively) as compared to placebo.
SEQUEL was a double-blind, placebo-controlled, three-arm, prospective study. Patients continued receiving the same treatment they had been randomized to in the CONQUER study in a blinded fashion: either once-a-day treatment with top-dose QNEXA (n=295), mid-dose QNEXA (n=153), or placebo (n=227). Throughout the 108-week treatment period, all patients were advised to follow a simple lifestyle modification program including reduction of food intake by 500 calories per day.
Specific SEQUEL findings include the following primary endpoints:
- Patients taking top- and mid-dose QNEXA achieved and maintained weight loss over two years of 11.4% and 10.4% of their initial body weight, respectively, as compared to placebo-treated patients with 2.5% weight loss (ITT-LOCF, p<0.0001).
- A majority of all patients taking QNEXA exceeded 10% weight loss, the goal established by the National Institutes of Health (NIH) to decrease the severity of obesity-associated risk factors.
- The percentage of patients achieving categorical weight loss of at least 5%, 10% and 15% on both QNEXA doses was statistically significant compared to placebo:
Categorical Weight Loss (ITT-LOCF) |
5% |
10% |
15% |
|
Top-dose |
79%* |
54%* |
32%* |
|
Mid-dose |
75%* |
50%* |
24%* |
|
Placebo |
30% |
12% |
7% |
|
*p<0.0001 vs placebo | ||||
Average weight loss over two years of therapy with QNEXA from the SEQUEL study is depicted in the following graph:
(Photo: http://photos.prnewswire.com/prnh/20100921/CG67932)
(Photo: http://www.newscom.com/cgi-bin/prnh/20100921/CG67932)
Treatment-emergent serious adverse event rates in SEQUEL were low (top-dose = 4.1%; mid-dose = 2.6%) and similar to placebo (4.0%), with no drug-related serious adverse events reported.
The completion rate in SEQUEL was approximately 83% for both QNEXA doses and 86% for the placebo group. Discontinuations due to adverse events were 3.9% and 4.1% for the mid- and top-dose, respectively; and 2.6% for the placebo group; with no single adverse event leading to discontinuation in more than 1% of patients.
Additionally, SEQUEL data confirms previous safety findings, with no evidence of suicidality and no reports of suicidal attempts or behavior. Depression assessments, as measured by the PHQ-9 clinical depression scale, improved from baseline for all treatment groups.
The incidence of targeted medical events for sleep disorders, depression, anxiety, cardiac disorders and cognitive disorders in SEQUEL was lower than observed during the one-year CONQUER study.
Similar to previously presented data, effects of QNEXA in SEQUEL on heart rate were small and seen in conjunction with improvements in blood pressure from baseline. There were no clinically relevant decreases of serum bicarbonate in QNEXA-treated patients compared to placebo in year two of SEQUEL.
Across the entire QNEXA development program (4,323 patients), including the two-year data in SEQUEL, serious cardiovascular and neurovascular adverse event rates in patients taking QNEXA were similar to placebo with a relative risk of 0.59 (95% CI: 0.33-1.06). No teratogenic effects were observed across the entire development program in patients taking QNEXA.
“These two-year data provide further reassurance that QNEXA may fill a significant medical need for this at-risk, co-morbid population struggling to lose weight and keep it off,” said Leland Wilson, chief executive officer of VIVUS. “We look forward to presenting and publishing additional data from SEQUEL, including secondary efficacy endpoints for decreasing co-morbidity risks, in the future.”
About QNEXA Controlled Release Capsules
QNEXA [kyoo-nek-suh] is an investigational drug being developed to address weight loss, type 2 diabetes and obstructive sleep apnea. QNEXA is a once-a-day, proprietary, oral, controlled-release formulation of low-dose phentermine and topiramate, which together decrease appetite and increase satiety (the sense of feeling full), the two main mechanisms that impact eating behavior. In phase 2 and 3 clinical data to date, patients taking QNEXA have demonstrated statistically significant weight loss, glycemic control, and improvement in cardiovascular risk factors, when used in combination with a diet and lifestyle modification program.
VIVUS submitted a New Drug Application (NDA) to FDA in December 2009 seeking approval of QNEXA for the treatment of obesity, including weight loss and maintenance of weight loss, in patients who are obese or overweight with co-morbidities such as hypertension, type 2 diabetes, dyslipidemia or central adiposity. An action date has been set for October 28, 2010.
About Obesity
Approximately one-third of American adults (more than 72 million people) are obese, and many more are overweight with co-morbidities. Obesity is a chronic condition defined by having excess body fat. Obesity significantly increases the risk of developing many different diseases and health conditions, including type 2 diabetes, hypertension, metabolic syndrome, cardiovascular disease, some cancers and osteoarthritis. According to a report in The Lancet in 2009, morbid obesity shortens life expectancy by approximately 10 years, and moderate obesity shortens it by approximately 3 years.
In August of this year, the Centers for Disease Control and Prevention (CDC) called attention to the “major public health problem” of obesity by issuing a national report citing the lack of progress against goals established 10 years ago by the federal government. The CDC reported that all 50 states failed to meet the “Healthy People 2010” goal of lowering the obesity rate to 15%, and some states actually reported a significant increase in obesity rates.
About VIVUS
VIVUS is a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health. The company’s lead product in clinical development, QNEXA®, has completed phase 3 clinical trials for the treatment of obesity and an NDA has been filed and accepted by the FDA, with an action date of October 28, 2010. QNEXA is also in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea. In the area of sexual health, VIVUS is in phase 3 development with avanafil, a PDE5 inhibitor being studied for the treatment of erectile dysfunction. MUSE® (alprostadil), a first generation therapy for the treatment of ED, is already on the market and generating revenue for VIVUS. For more information about the company, please visit www.vivus.com.
Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as “anticipate,” “believe,” “forecast,” “estimated” and “intend,” among others. These forward-looking statements are based on VIVUS’ current expectations and actual results could differ materially. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, substantial competition; uncertainties of patent protection and litigation; uncertainties of government or third party payer reimbursement; reliance on sole source suppliers; limited sales and marketing efforts and dependence upon third parties; risks related to the development of innovative products; and risks related to failure to obtain FDA clearances or approvals and noncompliance with FDA regulations. As with any pharmaceutical under development, there are significant risks in the development, regulatory approval and commercialization of new products. There are no guarantees that future clinical studies discussed in this press release will be completed or successful or that any product will receive regulatory approval for any indication or prove to be commercially successful. VIVUS does not undertake an obligation to update or revise any forward-looking statement. Investors should read the risk factors set forth in VIVUS’ Form 10-K for the year ended December 31, 2009 and periodic reports filed with the Securities and Exchange Commission.
Trintech (TTPA) to Speak at IQPC Finance Transformation 2010
DALLAS, DUBLIN, Ireland and LONDON, Sept. 21, 2010 (GLOBE NEWSWIRE) — Trintech Group Plc (Nasdaq:TTPA), a leading provider of integrated financial governance, risk management and compliance (GRC) software solutions, announced today that Theresa Clark, Trintech’s Vice President of Finance Transformation, will be a featured speaker at the upcoming IQPC Finance Transformation Conference on Wednesday, September 29, 2010. Ms. Clark will be joined by Trintech customer Jo Allen, Financial Services Accounting Manager for Koch Industries, in a case study entitled “Workhorse Technologies: Leveraging Automation to Deliver Productivity…and Profits“.
“Finance talent should be focused on critical business issues,” said Ms. Clark, “not mired in manual tasks that technology can automate with a surprising level of accuracy and detail. Configurable workflow technologies such as Trintech’s Unity Financial GRC Software suite can help businesses improve overall productivity by embedding critical processes such as, scheduling, financial reporting, and compliance into daily financial operations.”
- What: Workhorse Technologies: Leveraging Automation to Deliver Productivity…and Profits
- Who: Theresa Clark, VP Finance Transformation (Trintech) and Jo Allen, Financial Services Accounting Manager (Koch Industries)
- When: Wed 9/29 1:30 PM CDT
- To Register: http://www.fintransformation.com/Event.aspx?id=322838
Attendees will learn how to determine which processes lend themselves to automation, hear about best practices in automation projects, and capitalize on the strategic advantage that comes with an advanced, automated production platform empowering the Office of Finance.
About Trintech Group
Trintech Group Plc (Nasdaq:TTPA) is a leading global provider of integrated financial governance, risk management, and compliance (GRC) software solutions for commercial, financial, and healthcare markets. Trintech’s recognized expertise in reconciliation process management, financial data aggregation, financial close and reporting, risk management, and compliance enables customers to gain greater visibility and control of their critical financial processes leading to better overall business performance.
For more information on how Trintech can help you increase confidence in business performance and reduce financial risk, please contact us online at www.trintech.com or at our principal business office in Addison, Texas, or through an international office in Ireland, the United Kingdom, or the Netherlands.
Trintech • 15851 Dallas Parkway, Suite 900 • Addison, TX 75001 • Tel 1 972 701 9802
Trintech UK Ltd. • Warnford Court, 29 Throgmorton St. • London EC2N2AT, UK • Tel +44 (0) 20 7628 5235
Trintech Technologies • Block C, Central Park • Leopardstown, Dublin 18, Ireland • Tel +353 1 293 9840
Trintech • Cypresbaan 9 • 2908 LT Capelle a/d Ijssel, The Netherlands • Tel +31 (0) 10 8507 474
CONTACT: Trintech Media Contact Dave Tomlinson (972) 739-1611 dave.tomlinson@trintech.com
Zoom Technologies, Inc. (ZOOM) Receives Additional Orders From Beijing Tianyu
BEIJING — (Marketwire) — 09/21/10 — Zoom Technologies, Inc. (NASDAQ: ZOOM), a leading China based manufacturer of mobile phones and related products, today announced it has received an increase in orders from Beijing Tianyu, its largest EMS customers. Beginning in the fourth quarter of 2010, Beijing Tianyu will increase its orders by an additional 500,000 units per month, or 1.5 million units per quarter, when fully ramped. Before the increase, Zoom’s orders from Beijing Tianyu were about 2.2 million units per quarter, comprising of approximately half in PCBA (main circuitry) units and half in whole mobile phones.
Mr. Lei Gu, Chairman and Chief Executive Officer of Zoom Technologies, stated, “The increase in mobile phones manufactured by Zoom Technologies directly reflects the strength of the Chinese macroeconomic environment, the robust mobile phone industry and Zoom’s strategy to gain market share. We highly value the confidence Tianyu has expressed in Zoom Technologies and we share the same goals of expansion and technology development. Also propelling Zoom’s market opportunity is China’s low penetration rate in mobile phone usage of only 55%, as compared to over 90% in many developed countries.”
About Zoom Technologies
Zoom Technologies is a holding company with subsidiaries that engage in the manufacturing, research and development, and sale of electronic and telecommunication products for 3rd generation mobile phones, wireless communication circuitry, and related software products. Zoom Technologies’ subsidiary, Jiangsu Leimone, owns a majority stake of TCB Digital, which offers highly customized and high quality Electronic Manufacturing Service (EMS) for Original Equipment Manufacturer (OEM) customers as well as its Own Brand Manufacturing (OBM) under the brand name of Leimone. The company’s products are both exported and sold domestically.
Forward-Looking Statements
Certain statements in this press release may constitute “forward looking statements” that involve risks and uncertainties. These include statements about our expectations, plans, objectives, assumptions or future events. You should not place undue reliance on these forward-looking statements. Information concerning factors that could cause our actual results to differ materially from these forward-looking statements can be found in our periodic reports filed with the Securities and Exchange Commission. We undertake no obligation to publicly release revisions to these forward-looking statements to reflect future events or circumstances or reflect the occurrence of unanticipated events.
Investor Relations Contact:
Cynthia Hiponia
The Blueshirt Group
415-217-4966
iGo, Inc. (IGOI) Teams with Cisco’s Flip Video for “Designed for Flip” Accessory Program
SCOTTSDALE, Ariz., Sep 20, 2010 (BUSINESS WIRE) — iGo, Inc. /quotes/comstock/15*!igoi/quotes/nls/igoi (IGOI 1.75, +0.15, +9.38%) , a leading provider of mobile accessories and power management solutions, has teamed with Cisco’s Flip Video and the new Designed for Flip(TM) Accessory Program to create accessories compatible with the popular Flip Video cameras. As part of the program, iGo will offer a number of new products, including a custom Flip iGo Charge Anywhere, the new iGo Overtime Backup Battery and the new iGo Pocket Projector.
“iGo is excited to team with Flip Video to help launch the new Designed for Flip Accessory Program. Flip Video is a well established brand with portable and easy-to-use products that perfectly align with iGo,” said Michael D. Heil, president and chief executive officer of iGo. “The iGo products included in the Designed for Flip accessory program allow Flip Video camera users to always have enough power, plus the ability to show videos while on the go.”
Working with the new FlipPort(TM), a proprietary connector on the new Flip UltraHD 8 GB/2 hour video camera, iGo’s battery charger and backup battery accessories easily plug right into Flip Video cameras. The iGo Pocket Projector uses the HDMI port found on most Flip Video cameras. The iGo product line up compatible with Flip Video cameras includes:
— iGo Pocket Projector (MSRP $349.99): The lightest, slimmest pocket projector on the market (also known as a pico projector), iGo’s UP-2020 battery powered Pocket Projector displays videos directly from a Flip Video camera on any flat surface. Bundled with HDMI-Mini and HDMI-Micro cables, the UP-2020 connects directly to all the latest Flip Video HD cameras, as well as other devices like laptops, netbooks, smartphones, digital cameras and mobile gaming systems, displaying 16:9 widescreen images up to 70″ wide.
— iGo Flip-specific Charge Anywhere (MSRP $49.99): A backup battery and wall charger in one device that allows users to charge two devices simultaneously and then uses the battery power when you’re away from an outlet. The special FlipPort-enabled Charge Anywhere is bundled with a FlipPort USB cable that allows for convenient charging of your Flip camcorder at home, in the office or on the go.
— iGo Overtime Backup Battery (MSRP $29.99): A rechargeable battery that is sized perfectly for connecting to your Flip Video camcorder via the FlipPort, the Overtime Backup Battery will add at least another hour, ensuring you don’t miss the end of the play, game or whatever you’re recording.
“Having iGo as part of our Designed for Flip accessory program helps us extend the fun of the Flip experience by enabling our consumers to take their video cameras to more places with iGo’s selection of charging accessories,” said Jodi Lipe, Cisco Consumer Products. “Also the iGo Pocket Projector takes home family movie night to another level of fun by instantly projecting all their favorite Flip Videos on any flat surface indoors or outside.”
The iGo Flip Video products are available at www.iGo.com/flip and www.theflip.com. For more information about iGo, please visit www.iGo.com.
About iGo, Inc.
iGo, Inc., based in Scottsdale, Arizona, is a leading provider of power management solutions, including eco-friendly chargers, and accessories for laptop computers and mobile electronic devices (e.g., mobile phones, PDAs, digital cameras, etc.). iGo is also the creator of the new, innovative patent-protected power saving technology, iGo Green(R) Technology, that automatically eliminates wasteful and expensive standby or “vampire” power that is generated from chargers continuing to draw electricity when a mobile electronic device no longer requires charging or is disconnected from the charger. iGo’s chargers also leverage iGo’s intelligent tip technology, which significantly minimizes electronic waste by enabling one charger to charge hundreds of brands and thousands of models of mobile electronic devices through the use of interchangeable tips. In addition to iGo’s innovative power management solutions, iGo continues to add new, novel mobile electronic accessories consistent with its vision to attach its products and technology to every mobile electronic device.
iGo’s products are available at www.iGo.com as well as through leading resellers and retailers. For additional information call 480-596-0061, or visit www.igo.com.
iGo is a registered trademark of iGo, Inc. and its affiliates. All other trademarks or registered trademarks are the property of their respective owners.
About Cisco
Cisco /quotes/comstock/15*!csco/quotes/nls/csco (CSCO 21.67, -0.19, -0.88%) is the worldwide leader in networking that transforms how people connect, communicate and collaborate. This year celebrates 25 years of technology innovation, operational excellence and corporate social responsibility. Cisco’s vision for the consumer is to enable people to live a connected life that is more personal, more social, and more visual. Further information about Cisco and its full line of consumer products including Linksys, Valet and Flip Video can be found at www.theflip.com, http://home.cisco.com and www.cisco.com/consumer.
SOURCE: iGo, Inc.
Gulfstream International Group (GIA) Receives $8.5 Million of Federal Subsidies for Essential Air Service Contracts for Routes to Cleveland
Sep. 20, 2010 (Business Wire) — Gulfstream International Group, Inc. (“Gulfstream” or the “Company”) (AMEX: GIA) announced today that it will receive $8.5 million in federal subsidies as part of the Essential Air Service Program for five routes for small communities around Cleveland, OH.
As announced earlier, the U.S. Department of Transportation (“DOT”) has awarded the Company new two-year contracts as the Essential Air Service provider for the communities of Bradford, PA; DuBois, PA; Franklin/Oil City, PA; Parkersburg, WV; and Jamestown, NY. Gulfstream operates flights from all five cities to Cleveland.
The federal funds are granted under the Essential Air Service Program, which was instituted to ensure that small communities, which were previously served by certified air carriers before deregulation, maintain a minimal level of scheduled air service. The DOT currently subsidizes commuter airlines to serve approximately 140 rural communities across the country that otherwise would not receive any scheduled air service.
David Hackett, CEO of Gulfstream, said, “We believe we provide the right fit to these communities; as a niche operator with a unique aircraft size, we are able to efficiently connect these smaller markets to expanded air service. We strive to offer excellent customer service in all our markets, and will continue to seek out new markets for growth, particularly those represented by the Essential Air Service Program.”
About Gulfstream International Group, Inc.
Gulfstream currently operates 23 aircraft with over 150 daily system departures throughout Florida, the Bahamas and now with service at Cleveland, OH. Gulfstream also has codeshare relationships with several major air carriers. The Company, with its headquarters in Ft. Lauderdale, has approximately 500 employees, the bulk of which are Florida based. Gulfstream is a member of the Regional Airline Association.
Special Note Regarding Forward-Looking Statements
In addition to historical information, this release contains forward-looking statements. Gulfstream may, from time-to-time, make written or oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to, among other things: its business strategy; its efficiency; its value proposition; the market opportunity for its services, including expected demand for its services; and any other plans, objectives, expectations and intentions contained in this release that are not historical facts.
These statements, in addition to statements made in conjunction with the words “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “estimate” and similar expressions, are forward-looking statements. These statements relate to future events or future financial performance and only reflect management’s expectations and estimates. All forward-looking statements included in this release are made as of the date hereof and are based on information available to Gulfstream as of such date. The following is a list of factors, among others, that could cause actual results to differ materially from the forward-looking statements: changes to external competitive, business, budgeting, fuel cost or supply, weather or economic conditions; changes in its relationships with employees or code share partners; availability and cost of funds for financing new aircraft and the ability to profitably manage its existing fleet; adverse reaction and publicity that might result from any accidents; the impact of current or future laws and government investigations and regulations affecting the airline industry and its operations; additional terrorist attacks; and consumer unwillingness to incur greater costs for flights.
Gulfstream assumes no obligation to update any forward-looking statement. Risk factors, cautionary statements and other conditions which could cause actual results to differ from management’s current expectations are contained in Gulfstream’s filings with the Securities and Exchange Commission, including Part I, Item 1A, “Risk Factors,” of its Annual Report on Form 10-K for the Year Ended December 31, 2009 and subsequent Form 10-Q filings.
TraderPower Featured Companies
Top Small Cap Market News
- $SOBR InvestorNewsBreaks – SOBR Safe Inc. (NASDAQ: SOBR) Closes on $8.2M Private Placement
- $CLNN InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Participation at Two Upcoming Investor Conferences
- $ATBHF Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Releases Updated Report on Storm Copper Project Drilling Program
- $LGVN InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Present at This Month’s Congenital Heart Surgeons’ Society Annual Meeting
- $LEXX InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins Subject Dosing in Human Pilot Study #3 Evaluating Oral DehydraTECH-Processed Tirzepatide
- $FSTTF InvestorNewsBreaks – First Tellurium Corp. (CSE: FTEL) (OTC: FSTTF) Shares Additional Information on the PyroDelta Thermoelectric Generator, Relationship with Subsidiary
- $TMET.V Gold Stutters as Strong US Jobs Data Dampens Expectations of Large Rate Cuts
- $RFLXF JPMorgan Executive Says US Backlash Against ESG Is Exaggerated
- $SFWJ InvestorNewsBreaks – Software Effective Solutions Corp. (d/b/a MedCana) (SFWJ) Releases Report on Series of Acquisitions, Multiple Cannabis Licenses
- $EAWD IEA Hosts G20 Ministers, Influential Personalities to Discuss Clean and Affordable Energy Transition
Recent Posts
- $EAWD IEA Hosts G20 Ministers, Influential Personalities to Discuss Clean and Affordable Energy Transition
- $SFWJ InvestorNewsBreaks – Software Effective Solutions Corp. (d/b/a MedCana) (SFWJ) Releases Report on Series of Acquisitions, Multiple Cannabis Licenses
- $RFLXF JPMorgan Executive Says US Backlash Against ESG Is Exaggerated
- $TMET.V Gold Stutters as Strong US Jobs Data Dampens Expectations of Large Rate Cuts
- $FSTTF InvestorNewsBreaks – First Tellurium Corp. (CSE: FTEL) (OTC: FSTTF) Shares Additional Information on the PyroDelta Thermoelectric Generator, Relationship with Subsidiary
- $LEXX InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins Subject Dosing in Human Pilot Study #3 Evaluating Oral DehydraTECH-Processed Tirzepatide
- $LGVN InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Present at This Month’s Congenital Heart Surgeons’ Society Annual Meeting
- $ATBHF Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Releases Updated Report on Storm Copper Project Drilling Program
Recent Comments
Archives
- October 2024
- January 2023
- June 2022
- December 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009